Lorillard
Final Report I-1729.005 Six Week Repeated Smoke Inhalation in Mice to Compare Histopathology and Short-Term Endpoints Using Test (D6 and D10) and Reference Cigarettes
Fields
- Author
- David, R.M.
- Hall, W.C.
- Johnson, A.
- M, D.
- Hall, W.C.
- Area
- LIFE SCIENCE LAB 20/BASEMENT GMP
- Alias
- 88975978/88976079
- Type
- SCRT, SCIENTIFIC REPORT
- BIBL, BIBLIOGRAPHY
- CHAR, CHART/GRAPH/MAPS
- BIBL, BIBLIOGRAPHY
- Recipient (Organization)
- Lor, Lorillard
- Named Person
- Bertalanffy
- Brown
- Dansie, D.R.
- David, R.M.
- Dixon
- Dungworth
- Guerin
- Henry
- Kanagalingam
- Kouri
- Lamb
- Minnemeyer, H.J.
- Reid
- Rohlf
- Sokal
- Stone, C.
- Young
- Brown
- Document File
- 88975926/88976172/I1729.005
- Date Loaded
- 05 Jun 1998
- Named Organization
- Cigarette Components Uk
- Crl, Charles River Breeding Lab
- Micro, Microbiological Associates
- Process + Instruments
- Crl, Charles River Breeding Lab
- Litigation
- Stmn/Produced
- Author (Organization)
- Micro, Microbiological Associates
- Site
- G41
- Request
- R1-058
- Master ID
- 88975974/6079
Related Documents:- 88975974 Draft to Final Report Study No.: I-1729.005 Report: 'six Week Repeated Smoke Inhalation in Mice to Compare Histopathology and Short-Term Endpoints Using Test (D6 and D10) and Reference Cigarettes'
- 88975975-5976
- 88975977 Protocol Amendment Protocol Number: I-1729.005 Protocol Title: 'six Week Repeated Smoke Inhalation in Mice to Compare Histopathology and Short-Term Endpoints Using Test (D6 and D10) and Reference Cigarettes'
- UCSF Legacy ID
- baj90e00
Document Images
Final Report
1-1729.005
SIX WEEK REPEATED SMOKE INHALATION
IN MICE TO COMPARE HISTOPATHOLOGY AND
SHORT-TERM ENDPOINTS USING TEST (D6 and D10)
AND REFERENCE CIGARETTES
Final Report
For
Lorillard Research Center
420 English Street
P.O. Box 21688
Greensboro, North Carolina 27420
September 25, 1985
By
Microbiological Associates Inc.
5221 River Road
Bethesda, Maryland 20816

Final Report
I-1729.005
Table of Contents
Page
I. Data Page 3
II. Introduction 4
III. Purpose 6
IV. Reference and Test Cigarette Characterization 7
V. Test Description 9
VI. Materials and Methods 10
VII. Results and Discussion 16
A. General Toxicology 16
B. Clinical Chemistry and Hematology 19
VIII. Conclusions 21
IX. Figure and Tables 22
X. References 23
XI. Quality Assurance Statement 25
XII. Appendix A - Pathology Report
2

Final Report
I-1729.005
I. DATA PAGE
Cigarette Identity: Reference, Test Cigarettes D6 and D10
Dates Samples Received: June 9, 1982 (Reference)
February 4,1983 (D6 and D10)
Date Sample Returned: Retained in storage
Initiation Date: March 24,1983
Completion Date: See Review Completed Date: Page 24
MA Experiment Number: 1-1729.005
MA Notebook Number: 1729.005
Archives Location: 5221 River Road, Bethesda, Maryland 20816
Sponsor: Lorillard Research Center
420 English Street
P.O. Box 21688
Greensboro, North Carolina 27420
Authorized Representative: Harry Minnemeyer, Ph.D.
Connie Stone, Ph.D.
Testing Facility: Microbiological Associates Inc.
5221 River Road
Bethesda, Maryland 20816
Lead Technician: Dj6vhd R. Dansie
~
Study Director: Rayny§nd M~-Bwid, Ph.D.
'r Z i S'j---
Da e
3

Final Report
I-1729.005
II. INTRODUCTION
Alterations in the morphology of the respiratory tract have
been noted in animals exposed to whole cigarette smoke. The
magnitude of the changes depend upon the species, the cigarette
type, the smoke exposure regimen or dose, and the duration of the
exposure.
Recent reports have detailed procedures for standardized
microscopic examination of the upper respiratory tract (Young,
1981) which complement the procedures for evaluation of the lower
respiratory tract. These procedures permit visualization of the
nasal passage, trachea, major bronchi, terminal airways and lung
parenchyma (Dungworth et al, 1976). Thus a detailed evaluation
will be performed on the following tissues from animals exposed
to smoke for six weeks:
0 nasal cavity and nasal turbinates
0 oral cavity, larynx, and pharynx
0 trachea
0 lungs and bronchi
0 any other abnormal tissues
In addition to the microscopic evaluation, the following 4 assays
complement the histopathology endpoints and were performed on the
same group of animals at the same time. These particular assays
have been grouped together to most efficiently utilize the Walton
Smoking Machine with 12 mice/machine.
Clinical Chemistry:
Changes in clinical chemistries can reflect generalized
toxic effects to the lung, liver, kidney, heart or other organs
by the alteration of specific blood enzyme levels (i.e., lactic
dehydrogenase), blood glucose, blood urea nitrogen, ion or metal
levels, and total protein levels.
Hematology Assays:
Hematologic changes can reflect the effects of a large
number of chemicals or agents on the blood and blood-forming
organs, either directly or indirectly. Decreased or increased
numbers of erythrocytes or leukocytes in the peripheral blood can
reflect diseased or toxic states.
4

Final Report
I-1729.005
Metabolism - Microsomal Monooxygenase (MMO) Levels:
Aryl hydrocarbon hydroxylase (AHH) is one of the microsomal
monooxygenases and represents the enzymatic complex responsible
for the metabolism of polycyclic hydrocarbons, such as
benzo(a)pyrene (BaP), benz(a)anthracene, or 3-methylcholanthrene.
It is present in most mammalian tissues and can be enhanced in
animals by the administration of a variety of chemicals such as
the polycyclic hydrocarbons themselves, 5,6-benzoflavone, or
2,3,7,8- tetrachlorodibenzo-p-dioxin (Kouri and Nebert, 1977).
The enzyme is detected in a fluorometric assay which quantifies
the conversion of BaP to 3-hydroxy-BaP. AHH levels will serve as
internal markers in tissues for particulate deposition or
redistribution after smoke exposure. Comparative levels of AHH
in lung, liver, and kidney between cigarette types would allow
differences in deposition, absorption, and redistribution to be
observed. This may be particularly important if additives to the
particulate phase involve AHH inducers.
Cellular Proliferation:
Cell turnover or replication can be estimated by either
mitotic indices or incorporation of 3H-thymidine into DNA. These
techniques are sensitive criteria indicating possible induced DNA
or cellular damage, where no evidence of damage can be seen by
histologic appearance (Lamb and Reid, 1968). Cigarette smoke has
been shown to induce cellular proliferation in mice (Kanagalingam
et al, 1982). Mitotic counts can be evaluated in the same
slides (and animals) used for "general" histopathologic
evaluations (Bertalanffy, 1964) and can be easily incorporated
into these studies.
5

Final Report
I-1729.005
III. PURPOSE
The purpose of this study is to compare the response of
animals exposed to smoke from the Reference cigarette with smoke
from two test cigarettes using histopathology of the respiratory
tract and selected short-term endpoints.
6

Final Report
1-1729.005
IV. CIGARETTE CHARACTERIZATION
Approximately 2000 Reference cigarettes were received on
June 9, 1982, and 1200 D6 test cigarettes, and 1200 D10 test
cigarettes were received by Microbiological Associates Inc. on
February 4, 1983. The Reference cigarette was assigned a
registry number of 5, D6 a registry number of 14, and D10 a
registry number of 15. Characterization of cigarette smoke was
performed each week and included determination of
resistance-to-draw (RTD), butt length, and wet total particulate
matter (TPM) per cigarette. RTD was measured using a Filtrona
Pressure Drop Tester (Cigarette Components UK Ltd., Wembley,
England). Butt length was measured after burning cigarettes with
7 puffs/cigarette. TPM was collected onto Cambridge filter pads
from each cigarette after burning on the Walton Horizontal
Smoking Machine. The standardized conditions for burning
cigarettes were the same as those used for exposing the animals
(7 puffs). The following data were collected:
Cigarette RTD Butt TPM
Type (mm H20) Leygt~ (mg)
mm
Week 1
Reference 79.7 + 0.6 44.7 + 2.1 15.3 + 0.2
D6 101.7 + 6.0 47.3 + 2.3 13.8 + 0.4
D10 88.0 + 2.6 47.0 + 5.6 14.4 + 0.6
Week 2
Reference 80.0 + 1.4 44.0 + 4.2 14.9 + 0.1
D6 102.3 + 4.6 51.0 + 6.0 10.7 + 0.5
D10 95.5 + 10.6 49.0 + 2.8 12.3 + 0.1
Week 3
Reference 80.7 + 2.1 40.3 + 3.5 18.1 + 0.3
D6 95.3 + 11.0 47.7 + 2.5 13.0 + 0.3
D10 91.7 + 1.5 49.3 + 4.7 15.4 + 0.4
Continued...
7

Final Report
I-1729.005
Cigarette RTD Butt
Type
(mm A20) Length
T PM
(mg)
---------------------------------------------------------
Week 4
Reference 89.3 + 4.0 44.0 + 4.0 15.5 + 0.4
D6 101.5 + 2.1 45.5 + 0.7 15.3 + 0.1
D10 100.5 + 7.8 52.5 + 3.5 13.8 + 0.8
Week 5
Reference 83.5 + 0.1 40.0 + 5.7 14.5 + 0.2
D6 104.0 + 1.4 46.0 + 1.4 13.6 + 0.5
D10 95.5 + 7.8 47.5 + 0.7 16.7 + 2.8
Week 6
Reference 84.0 + 1.4 46.5 + 2.1 13.5 + 2.8
D6 103.5 + 0.7 45.5 + 0.7 15.8 + 0.4
D10 87.0 + 4.2 49.0 + 1.4 15.3 + 0.1
The Sponsor specified storage at room temperature and no
expiration date was provided.
For the purposes of this study, the test articles were
stored in the original cellophane sealed boxes in a secured area
at room temperature.
8

Final Report
I-1729.005
V. TEST DESCRIPTION
B6C3F1/Cr1BL mice were exposed to smoke from two test
cigarettes and the Reference cigarette. The exposure regimen used
(7 puffs, RSD1) was decreased from that used (8 puffs, RSD1) in
the acute toxicity study (I-1729.003) to reduce toxicity and
ensure adequate survival.
At weekly intervals, mice were weighed and monitored for
levels of carboxyhemoglobin (COHb). Three mice/group were
sacrificed after 3 weeks exposure to determine microscopic
appearance of the respiratory tract, clinical chemistry, and
hematology. After 6 weeks exposure, 3 mice/group were sacrificed
to determine microscopic appearance of the respiratory tract,
clinical chemistry, and hematology; another 3 mice/group were
sacrificed for respiratory tract histopathology and mitotic
counts in the same respiratory tissues; and the remaining 3
mice/group were sacrificed to determine AHH levels in lung,
liver, and kidney.
9

Final Report
I-1729.005
VI. MATERIALS AND METHODS
Materials
Animals: B6C3F1/Cr1BL mice, females
8 weeks old
Sendai vaccinated
Charles River Breeding Farms
Kingston, New York
Smoke Generation Equipment:
Walton Horizontal Smoking Machine (Walton)
Stock-like neck holders
Process and Instruments Corp.
Brooklyn, New York
Materials: Heparinized blood collecting tubes (250 ul)
IL-CO-Oximeter
Metofane anesthetic
Methods
Animals:
Animals were obtained from a source monitored and known to
be free of adventitious agents, vaccinated against Sendai virus
and quarantined for at least 21 days. Stringent disease control
procedures were followed during quarantine to assure the use of
healthy animals. Mice were observed for signs of illness,
unusual food and water consumption and other signs of poor
health. The animals were 12 weeks old at initiation of test and
were judged to be healthy prior to utilization.
Animals were housed in an AAALAC-accredited facility with a
controlled environment of 74 + 5 OF, 50 + 20% relative humidity,
and a 12 hour light/dark cycle. Mice were housed 6 per cage in
polycarbonate autoclavable cages with filter top cage lids.
Corn-cob bedding was used and animals had free access to
certified laboratory rodent chow which had been analyzed for
environmental contaminants. Water and food were provided ad
libitum, except during exposures on the smoking machines.
10

Final Report
1-1729.005
Treatment:
Animals were ear tagged and randomly assigned to 4 groups
of 12 animals each using the stratified sequence randomization
technique. Groups of mice (12 per group) were exposed to smoke
from two test cigarettes and the Reference cigarette using the
following defined exposure regimen on the Walton Smoking Machine
(Henry et al, 1980, Guerin et al, 1979):
10% (v/v) smoke concentration (-4 ug TPM/ml)
30 seconds smoke/30 seconds air/minute
7 puffs/exposure
9 exposures/day
63 puffs/day
7-8 minute rest periods between exposures
31.5 minutes total time/day exposed to smoke
-130 minute/day exposure period
This daily (5 days/week) exposure regimen over 6 weeks resulted
in:
270 total exposures
1890 total puffs
30 days exposed
Exposure controls were used which consisted of age-matched mice
loaded onto the smoking machine, treated exactly as the test
animals, the machines set and run but without cigarettes. This
sham-control group was also treated for approximately -130
minutes. The following designates the disposition of the
animals:
Group Description
1 Reference Cigarette
2 Test Cigarette 1 (D6)
3 Test Cigarette 2 (D10)
4 Sham-Exposed Control
Animals were weighed 24 hours prior to the first exposure
and weekly thereafter during treatment. Blood carboxyhemoglobin
(COHb) levels were monitored in 2 mice/group at weekly intervals.
11

Final Report
I-1729.005
Animals were observed during the test period for any unusual
persistent conditions.
Sacrifices:
Animals were weighed to the nearest tenth of a gram prior to
necropsy. Animals were anesthetized with Metofane. Blood
samples from 3 animals/group at 3 weeks and 6 weeks were
collected for clinical chemistry and hematology. Animals were
killed by exsanguination.
Necropsy:
The necropsy is defined as external examination, including
body orifices, and gross examination and fixation in 10% formalin
of all of the following tissues and organs:
Spinal cord (thoracic)
Brain
Eye (R)
Pituitary
Trachea
Larynx
Esophagus
Adrenals (R & L)
Thyroids (R & L)
(with parathyroids)
Lungs & Bronchi (R & L)
Kidneys (R & L)
Liver
Spleen
Thymus
Any gross lesions
Salivary gland (R)
Mandibular lymph node
Mesenteric lymph node
Sternum (bone marrow)
Zymbal's gland (R)
Heart
Thigh muscle (R)
Sciatic nerve (R)
Stomach
Small intestine
Pancreas
Large intestine
Turbinates
Sk in
Urinary bladder
Females
(R) = Right (L) = Left
Ovaries (R & L)
Uterus
Mammary gland
Gross observations made during necropsy were recorded on an
individual animal necropsy form containing the animal
identification number, group number, compound administered, date
of death, necropsy date, signature block, study number, and other
pertinent information. In addition, all tissues taken at
necropsy were recorded on the necropsy form. Jars containing
animal tissues were labelled with species, animal number, study
number, date of necropsy and technician initials.
12

Final Report
I-1729.005
The trachea was transected midway between lung and tongue,
and the heart, thymus and extraneous tissues were carefully
removed. The lung was weighed to the nearest milligram, and
perfused with fixative via the trachea to approximate the normal
expanded size.
Histology:
0 Lungs - The preferred planes of section for rodents' lungs
are illustrated in Dungworth et al, 1976. These were sections
from the hilus along the axis of major airways for the cranial,
middle and caudal lobes of the right lung and longitudinally
through the main stem bronchus of the left lobe. Sections in
this plane for each lobe revealed bronchial and acinar
orientations of lesions much more readily. All of these blocks
can be sectioned whole for microscopic examination.
0 Larynx - The larynx was transected from the trachea. Three
transverse sections were taken from the larynx with the thyroid
and parathyroids attached, one from the distal portion (vocal
folds and caudal cricoid region), one from the middle portion
(arytenoid projections and ventral pouch) and one from the
proximal region (epiglottis). This will enable all major regions
to be assessed.
0 Trachea and bronchial bifurcation - A block containing a
longitudinal section of distal trachea (distal to larynx) was
prepared to include the bronchial bifurcation. The bifurcation
is a site sensitive to injury in inhalation studies because it is
the major location where air flow changes direction and particles
are likely to impinge. Only the respiratory tract organs were
processed for histopathology at this time. Lung tissues were
embedded in glycol methacrylate and sectioned at 2.5 microns.
The remaining fixed tissues are being held until data are
analyzed. Final disposition will be determined after
consultation with the Sponsor.
Blood Collections:
Blood collections were made from retro-orbital sinus
puncture or from anesthetized animals by cardiac puncture after
access was gained by incision. Approximately 0.3 ml blood was
used for hematology with potassium ethylenediaminetetraacetate
(K-EDTA). K- EDTA was used as the anticoagulant since it does
not adversely affect the shape of the red blood cells. Blood
smears were prepared from a drop of fresh blood placed directly
on a glass slide, spread, air dried and fixed in methanol. Blood
for clinical chemistry was allowed to clot and serum separated
from the cells.
13

Final Report
I-1729.005
Clinical Chemistry:
The following clinical
Glucose (serum)
Blood Urea nitrogen (BUN)
Creatinine
Cholesterol
Triglycerides
Calcium
Protein, total (serum)
A/G Ratio
Hematology:
The following hematological
Segmented neutrophils count
Monocyte counts
Platelet cell counts
Red blood cell counts (RBC)
Basophil counts
Hematocrit value
Mitotic Counts:
Alkaline Phosphatase
Lactic dehydrogenase (LDH)
SGOT
SGPT
Uric-acid (serum)
Phosphorous
Albumin
tests were performed:
Lymphocyte counts
Eosinophil counts
Reticulocyte counts
White blood cell counts (WBC)
Hemoglobin concentration
For determination of mitotic indices in lung tissues,
immediately after the last smoke or sham exposure, 3
animals/group were injected with 0.1 mg colchicine per 100 g body
weight (Lamb and Reid, 1968). Four hours later, animals were
anesthetized with Metofane and killed by exsanguination.
Clinical chemistry and hematology were not determined on these
animals. Necropsies were performed as described above and
respiratory tissues examined microscopically.
The mitotic activity of the bronchial epithelial cells was
assessed. The number of nuclei of bronchial epithelium in
mitosis was expressed per 12 diameters of a microscopic field
using the 40x objective. Approximately 1000 cells were observed
in each specimen.
AHH Levels:
For determination of AHH levels, 6 hours after the last
smoke or sham exposure, 3 animals from each group were sacrificed
by CO asphyxiation and lungs, liver, and kidneys dissected away
from ?he carcass and weighed to the nearest 0.1 mg. Microsomes
were prepared according to Burke and Mayer (1974) and stored at
-70°C until assayed. AHH activity was determined by fluorometric
chemistry tests were performed:
14

Final Report
1-1729.005
measurement of the 3-hydroxy-BaP (3-OH-BaP) formed according to
Kouri et al. (1976). AHH units are expressed as pmole 3-OH-BaP
formedTi-n7mg microsomal protein.
Evaluation of Test Results
The survival in each group is presented, as are any unusual
observations during or after exposure over the 6 weeks. Blood
COHb levels from 2 mice per group at weekly intervals are also
presented. Individual animal weights 24 hours prior to exposure
and at weekly intervals after exposure during treatment are
presented for each group. Individual animal pathologies on the
respiratory tract from 9 animals per group are presented, 3
animals/group after 3 weeks and 6 animals/group after 6 weeks).
Total erythrocyte counts, total leukocyte counts,
hematocrit, hemoglobin, differential leukocyte counts, blood urea
nitrogen, blood glucose and other clinical chemistries from 3
animals/group sacrificed at 3 weeks and 6 weeks are presented.
After 6 weeks of treatment, the levels of AHH in lung, liver, and
kidney tissues from 3 animals/group and the Mitotic Index (MI) in
lung tissue from 3 animals/group were determined.
Statistical analyses of all the data presented were
performed using BMDP-79 Biomedical Computer Programs, P-series
(Dixon and Brown, 1979). Analysis of variance (ANOVA) was
performed comparing the equality of means between groups and an
F-statistic calculated. In addition, Levene's test for the
homogeneity of variances was calculated, as were Welch and
Brown-Forsythe statistics which assume unequal variances.
. The data were entered as a matrix and the group means for
each variable (column) compared, e.g. body weights of all animals
on test for 7 days. Because the program only accepts data in
matrix form, values that are not recorded must be entered into
the computer as "missing" as opposed to zero and are omitted from
analysis. Significant differences between individual means were
determined by calculating a least significant range using a
Studentized Range Test modified for unequal sample sizes (Sokal &
Rohlf, 1969).
Criteria For Determination of Valid Tests:
None of the sham-exposed animals should die or show signs of
toxicity. COHb levels in the smoke-exposed groups should be
statistically (p < 0.05) increased relative to the sham-exposed
controls.
15

Final Report
I-1729.005
VII. RESULTS AND DISCUSSION
A. General Toxicology
B6C3F1 mice were quarantined for at least 21 days prior to
use, during which time their health status was evaluated by
observation. The animals were 12 weeks old and were judged to be
healthy prior to the initiation of this study.
Groups of animals were exposed "nose-only" to whole
cigarette smoke generated on a Walton Horizontal Smoking Machine.
Test cigarettes D6 and D10, and the Reference cigarette, were
evaluated together using the 7 puff Reference Smoke Dose 1 (7
puffs, RSD1). This change from 8 to 7 puffs was adopted after
consultation with the Sponsor because the results of the acute
toxicity study (See Final Report, 1-1729.003) indicated that 7
puffs contained an amount of TPM that is equivalent to what has
been found with other test cigarettes. Weekly determinations of
TPM from the Reference and test cigarettes were taken and are
presented in Section IV. Cigarette Characterization. The results
indicate that the TPM varied only about 10-20% over a 6 week
period and were within historical limits. The smoke-exposed
groups were compared to a sham-exposed (no cigarette) control
group. The Reference, D6, and D10 cigarettes had been previously
evaluated using an 8 puff RSD1 regimen in an acute toxicity
study. The results of that acute toxicity study suggested that a
reasonably high dose of smoke could be given with good survival
predicted in longer periods of exposure (see Final Report
(1-1729.003) provided a change from 8 to 7 puffs was affected.
Smoke and sham-exposures were initiated on March 24, 1983, and
completed on May 4, 1983. Animals were treated 5 days/week for a
total of 30 exposure days.
One animal from Group 3 (#1173, test cigarette D10) died
during exposure on Day 12 after 63 exposures, and one animal from
Group 4 (#1187, sham-exposed) died during exposure on Day 19.
This sham-exposed animal was found dead at the end of exposure
and had not displayed any signs of struggling or toxicity. An
autopsy did not reveal any overt cause of death. It is presumed
that this animal died of accidental suffocation that was
unrelated to the exposure. Aside from these two cases, the 3
animals/group scheduled for sacrifice at 3 weeks on test were
sacrificed on schedule, with the remaining 6 animals/group
sacrificed as scheduled after 6 weeks (Table GT1).
Those animals sacrificed after 3 weeks received the
scheduled 135 exposures and 945 puffs over 15 treatment days.
While animals sacrificed after 6 weeks received the scheduled 270
exposures and 1890 puffs. Survival to the 7 puff, RSD1 regimen
for the Reference and D6 cigarette smoke was 100% and 92% for
smoke from cigarette D10. Survival to sham exposure was also 92%
because of one accidental death.
16

Final Report
I-1729.005
Animals were observed daily during and immediately after
exposure for any unusual responses to treatment. No unusual
responses were observed. Mice exposed to smoke were lethargic,
ataxic, and felt hypothermic. There was tearing of the eyes,
trembling, and shallow breathing observed after exposure. In
addition, mice that had been exposed to smoke from test cigarette
D10 were unable to walk and kept a prone position. Sham-exposed
mice appeared alert and active after exposure, with the exception
that occasional tearing of the eyes and rhinorrhagia was
observed.
The COHb levels from 2 mice per group determined at weekly
intervals are presented in Table GT2. The COHb values for the
smoke-exposed groups ranged from between 21.8 to 59.8% COHb. The
smoke-exposed mice had significantly higher COHb levels than did
sham-exposed controls (Studentized Range Test, p < 0.05; Table
GT2).
The individual animal weights 24 hours prior to the first
treatment and at weekly intervals thereafter are presented for
each group in Table GT3. Individual body weights for animals
from each group are also presented in histogram form in Tables
GT4 - GT10. Statistical descriptions for each group, as well as
an Analysis of Variance, may also be found in Tables GT4 - GT10.
The group means for each weekly interval are presented in Figure
1. All animal weights were relatively stable throughout the
study and Analysis of Variance indicated that the body weights of
the sham- and smoke-exposed groups were statistically the same
(Analysis of Variance, p > 0.05).
The lung weights of mice sacrificed after 6 weeks of
treatment are presented in Table GT11. Lungs were dissected away
from the thoracic viscera as described in the Methods, and
weighed before perfusion with formalin fixative. The mean and
standard deviations are presented for 3 animals/group. Analysis
of Variance did not indicate any significant differences (p >
0.05).
The AHH activities in the lung, liver, and kidneys of mice
exposed to smoke for 6 weeks are presented in Table GT12. No
increases were observed in the pulmonary or renal AHH activities
of smoke-exposed mice. The AHH activity in the liver of
smoke-exposed mice was increased above that in sham-exposed
controls, but the increases were not statistically significant
(ANOVA, p > 0.05). These findings do not compare well to results
obtained in previous studies, which have always indicated induced
AHH activity in the lungs of animals exposed to cigarette smoke.
The level of enzyme activity is also not as high as had been
obtained previously. This may be the result of the method used
to isolate microsomal enzymes. Instead of ultracentrifugation,
calcium chloride precipitation was used to pellet the microsomal
fraction of the cell homogenates. This procedure was done
because it is more rapid and does not require an ultracentrifuge.
Preliminary results using a positive control of microsomes from
17

Final Report
I-1729.005
animals treated with 3-methylcholanthrene had indicated that this
method would be satisfactory for subcellular isolation of
microsomes from smoke-exposed animals. However, the enzymes
prepared in this way may be more susceptible to denaturation
during freezing and thawing. As a result, calcium chloride
precipitation will no longer be used to prepare enzyme fractions.
Bronchial and tracheal epithelium were evaluated for changes
in cellular proliferation after final smoke or sham treatment at
6 weeks. Twelve randomly selected fields from lung and 5
randomly selected fields from tracheal sections of 3
animals/group were examined at high magnification (400x) for the
presence of mitotic figures. These fields represented
approximately 1000 bronchial or tracheal epithelial cells,
respectively. Very few mitotic figures were found in either the
smoke-exposed or sham-exposed groups (less than an average of 4
and 1 mitotic figures/1000 bronchial and tracheal epithelial
cells, respectively). These data suggest that increased numbers
of mitotic figures could not be associated with this dose
exposure regimen during a 4 hour colchicine treatment period.
18

Final Report
I-1729.005
B. Clinical Chemistry and Hematology
Clinical chemistry and hematology values for individual
animals are presented in Tables CCH1-CCH4 for animals sacrificed
after 3 weeks on test, and in Tables CCH28-CCH31 for animals
sacrificed after 6 weeks on test.
After 3 weeks on test, a few significant changes in the
clinical chemistries were observed. Triglycerides were elevated
in mice exposed to smoke from the Reference and D6 cigarettes as
compared to sham-exposed controls (Studentized Range Test, p <
0.05; Table CCH7), but not in mice exposed to smoke from
cigarette D10. However, inasmuch as the differences observed are
only slightly beyond normal values, and there is no concomitant
change in glucose or cholesterol levels, the results are not
believed to be biologically significant.
Serum creatinine and BUN were also elevated in all smoke
exposed groups in comparison to the sham-exposed mice
(Studentized Range Test, p < 0.05; Tables CCH8-CCH9). Elevation
in both of these parameters is probably indicative of a possible
decrease in glomerular filtration in the kidney. All the
remaining clinical chemistries were within normal limits.
Smoke-exposed mice also had significantly increased numbers
of leukocytes (Studentized Range Test, p < 0.05; Table CCH2O).
This appears to be a general response to smoke because the
differential count of leukocytes did not indicate any abnormal
cell populations. All the remaining hematology values were
within normal limits.
After 6 weeks on test, mice exposed to smoke from test
cigarettes D6 and D10 had elevated triglyceride levels when
compared to sham-exposed controls (Studentized Range Test, p <
0.05; Table CCH34). This was not the case in mice exposed to
smoke from the Reference cigarette. Although similar results
were observed after 3 weeks of exposure to smoke, the results do
not appear to be indicative of any specific pathologic condition.
As had been observed after 3 weeks of exposure, BUN was
elevated in all smoke exposed groups (Studentized Range Test, p <
0.05; Table CCH36). An elevation in BUN without a concomitant
change in creatinine may be the result of any number of 00
physiological effects and is not necessarily indicative of a m
pathologic condition (Coles, 1980). Thus, the biological ~
significance, if any, of the increase in BUN is not known. ~
A significant decrease in the A/G Ratio was observed in mice W
that had been exposed to smoke from test cigarette D6 when
compared to animals that were exposed to the Reference cigarette
and to sham-exposed controls (Studentized Range Test, p < 0.05;
Table CCH40). No differences were found among the other groups.
19

Final Report
I-1729.005
Since the differences observed were within normal limits, the
results are not believed to be biologically significant.
No differences in the hematology values of mice on test for
6 weeks were observed.
20

Final Report
I-1729.005
VIII. CONCLUSIONS
The criteria for a valid test were satisfied in that no
sham-exposed animals showed signs of toxicity and COHb levels for
the survivors in smoke exposed groups were significantly greater
than the sham-exposed group.
Overall survival for mice on test for 6 weeks was 100% for
those groups exposed to smoke from the Reference and D6
cigarettes, and 92% for animals exposed to smoke from test
cigarette D10. Survival in the sham-exposed group was also 92%.
However, because no signs of toxicity were observed in the
sham-exposed group, the one death that occurred can be attributed
to accidental suffocation.
No unusual signs of toxicity were observed in mice exposed
to test cigarette smoke. Body weight changes and lung weights
were statistically the same for all groups. The AHH assay was
found to be invalid for this 6 week study.
The clinical chemistry of mice sacrificed after 3 weeks on
test was somewhat altered from the control. However, the only
notable changes were for creatinine and BUN, which were both
elevated in mice exposed to smoke. Changes in these parameters
usually indicate a decrease in glomerular filtration (GFR),
caused by any number of physiological conditions. Inasmuch as
the changes occurred in all smoke exposed animals, the cause does
not appear to be test article related. Instead, a component of
all cigarette smoke, such as nicotine which is known to have
antidiuretic properties, may have caused the decrease in GFR.
Leukocytes were also increased in smoke exposed animals after 3
weeks on test, but this may be a general response to the smoke
and not test article related.
After 6 weeks on test, increased triglyceride levels were
observed in groups exposed to test cigarettes, and increased BUN
levels were observed in all smoke exposed groups. The biological
significance of these alterations is not clear. No differences
were observed in the hematological values of animals sacrificed
after 6 weeks.
In general, the mice tolerated the smoke exposure well and
no-unusual signs of toxicity were noted. Smoke related responses
were observed in the lungs of female mice exposed to smoke 5 days
each week for 3 and 6 weeks, respectively. The responses
included macrophage infiltration of alveoli and lymphoid
infiltration of the interstitial tissue between small airways and
vessels and infrequently around pulmonary vessels. Grossly, lung
discoloration was observed in most smoke-exposed mice, but not
sham controls. Control mice were essentially free of gross and
microscopic responses. No differences between reference smoke
and test article smoke exposed groups could be discerned.
21

IX. Figure and Tables
Final Report
I-1729.005
22

FIGJRF. 1
I
23
22
BODY WEICRIT DATA FROP4 1-1729.005
Final Report
1-1729.005
0
4
a o
N
19
18
5 10 15 20 25 30 35 40
DAYS ON TEST
000qjLsB?3

Final Report
I-1729.005
Table GT1
Disposition of Animals
Number of Animals Sacrificed/
Number of Animals Scheduled for Sacrifice
Group -
Cigarette Number of A
on Tes nimals
t 3 Weeks
6 Weeks
1-Reference 12 3/3 9/9
2-D6 12 3/3 9/9
3-DlO
12
2/3 a
9/9
4-Sham
12
2/3 b
9/9
--------------------------------------------------------------------
aAnimal #1173 died during exposure on Day 12.
bAnimal #1187 died during exposure on Day 19.

Final Report
1-1729.005
Table GT2
Percent Carboxyhemoglobin Levels in Mice
Days on Test
a
Group- 7 14 21 28 35 42 Mean +
Standard
Deviation
----------------------------------------------------------------------
b
1-Ref 40.7 45.8 45.2 21.8 30.5 34.3 36.3 + 8.6
35.2 51.6 33.3 34.4 24.8 37.5
2-D6
59.8
46.4
42.2
44.0
47.6
29.7
42.1 b
+ 8.6
49.8 40.0 42.8 39.2 34.9 29.3
3-D10
59.6
57.4
54.1
34.4
41.0
32.5
44.8 b,c
+ 12.1
57.6 54.4 46.7 22.4 34.7 43.1
4-Sham
2.2
1.4
2.2
2.7
2.7
1.3.
2.1 c
+ 0.5
1.7 2.3 1.3 2.2 2.6 2.1
aWithin 3-5 minutes after last exposure, 2 animals/group were bled
from the retro-orbital sinus for COHb determination.
bMean COHb values significantly higher (p < 0.05 Studentized Range
Test) from sham-exposed group.
COne animal from this group bled on successive weeks because of
attrition in that group.

TABLE GT3
INDIVIDUAL BODY WEIGHTS OF MICE ON TEST
Final Report
I-1829.005
C A S E 1 3 4 5 6 7 8 9
NO. LABEL CIG BEFORE DAY7 DAY14 DAY21 DAY28 DAY3S DAY42
---- -------- ---------- ---------- ---------- ---------- - -- ---------a ---------- ----------
1 1145 1(Ref) 21.500 19.900 20.600 20.200 MISSING MISSING MISSING
2 1146 1 22.200 20.700 20.700 20.600 a
MISSING MISSING MISSING
3 1147 1 21 20.700 19.300 20.400 MISSINGa MISSING MISSING
4 1148 1 20.400 19.700 20 20.700 20.700 20.400 22.400
5 1149 1 20.800 20.500 19.900 20.200 20.400 20.400 22.300
6 1150 1 22.200 20.400 20.500 21.200 20.900 21.300 22.200
7 1151 1 22.100 20.900 20.300 20.900 20 20.800 21.700
8 1152 1 21.600 20.500 20.500 20.700 20.300 20.600 21.400
9 1153 1 21.500 20.600 21.600 21.800 21.100 21.500 22.900
10 1154 1 21 19.200 19.600 21.300 19.600 20.300 21.300
11 1155 1 22.900 21.800 21.300 21.900 21.600 21.500 22.600
12 1156 1 21.800 21 21.100 22.100 20.600 21.600 22
13 1157 2(D6) 17.900 17.200 17.700 18.600 MISSINGa MISSING MISSING
14 1158 2 23.200 22 21.400 21.800 MISSINGa MISSING MISSING
15 1159 2 21.600 21.500 20.700 21.900 MISSINGa MISSING MISSING
16 1160 2 20.900 20.800 20.300 21.100 21.400 20.200 21.400
17 1161 2 20.700 20.700 20.500 21.100 20.800 20.200 21.400
18 1162 2 19.900 19.700 19.400 19.200 19.700 19.600 20
19 1163 2 20.900 20.900 20 20.200 20.300 20.400 21.800
20 1164 2 21.700 21.300 21.100 20.800 21 21 21.600
21 1165 2 20.200 19.700 20 20.300 19.600 20.200 21.300
22 1166 2 23.300 22.800 22.300 21.800 22.100 22.400 24
23 1167 2 21.600 20.600 21 21.400 21.600 21.800 21.500
24 1168 2 21.900 20.500 20.700 20.600 20.500 20.300 20.500
25 1169 3(D10) 21.200 20.600 20.600 21.400 MISSINGd MISSING MISSING
26 1170 3 20.700 19.700 19.600 20.800 MISSINGa MISSING MISSING
27 11.71 3 20.800 20.600 19.600 20.900 20.400 21 20.900
28 1172 3 22.100 20.600 20 21 21 21.200 20.700
29 1173 3 22.200 21.600 MISSING h MISSING MISSING MISSING MISSING
30 1174 3 20.200 19.800 20 20.100 20.700 21.100 20.900
31 1175 3 23.300 21.900 21.300 22.200 22.600 22.800 23
32 1176 3 20.500 20.600 20 20.500 20.500 20.800 21.800
33 1177 3 21.700 22.200 21 21.600 20.400 21.200 21.800
34 1178 3 22.900 21 21 20.500 21.800 20.600 21.200
35 1179 3 21.400 20.600 19.700 20.500 20.800 20.800 20.500
36 1180 3 21.200 21.400 21.700 22 21.800 21.900 23.300
37 1181 4 (Sham) 21.900 21.300 20.700 22.100 MISSINGa MISSING MISSING
38 1182 4 20.700 19.300 19.300 20.300 MISSINGa MISSING MISSING
39 1183 4 20.500 19.700 18.900 19.900 20 20.300 21.700
40 1184 4 21.800 21 20.500 22 21.600 21.500 22.900
41 1185 4 20.400 19.600 19.600 19.°00 21.200 20.500 21.700
42 11.86 4 20.500 20 20.500 20.400 20.800 20.400 21.900
43 1187 4 21.600 21.100 21.200 MISSiNGc MISSING MISSING MISSING
44 1188 4 20.400 19.500 19.900 21.100 20.200 20.800 21.500
45 1189 4 22.800 21.200 21.600 22.600 22 22.200 23.100
46 1190 4 21.800 20.300 20.700 21.100 21 20.100 21.700
47 1191 4 20.700 19.900 19.800 2u.500 20.600 20.500 21.700
48 1192 4 22.200 20.900 21 22.200 21.600 21.400 22.200
35acrificed after 3 weeks on test.
EQOy4Get3 hDied during exposure on Day 12.
c Di.ed durinq exposure on Day 19.

Final Report
1-1729.005
TABLE GT4
ANALYSIS OF BODY WEIGHTS 24 HOURS PRIOR TO EXPOSURE
REF I`6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
28.000)
27.000)
26.000)
25.000)
24.000)
23.000)* ** ** *
22.000)M**** **** M** *****
21.000)***** M** ***** M*
20.000)* ** x* ****
19.000)
18.000)
17.000)
16.000)
15.000)
14.000)
13.000)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 21.583 21.150 21.517 21.275
STD.DEV. .708 1.460 .958 .832
R.E.S.D. .720 1.396 1.007 .971
S. E. M. .204 .421 .277 .240
MAXIMUM 22.900 23.300 23.300 22.800
MINIMUM 20.400 17.900 20.200 20.400
SAMPLE SIZE 12 12 12 12
ALL GROUPS COMBINED **********************R*k***k** ANALYSIS OF VARIANCE TABLE
***************x***************
MEAN 21.381
STD.DEV. 1.012
R.E.S.D. .990
S. E. M. .146
MAXIMUM 23.300
MINIMUM 17.900
SAMPLE SIZE 48
*
* SOURCE S M F
U 0 S
UARES
*
* BETWEEN GROUPS 1.4873 3 .4958 .47 .7066
x WITHIN GROUPS 46.6858 44 1.0610
*
p > 0.05;
* TOTAL 48.1731 47 NOT SIGNIFICANT
**************-***********************h*************************R*****R*A************A******
* LEVENE'S TEST FOR EQUAL VARIANCES 3, 44 1.53 .2195
***************h*************************************#***#*********************A**A*M*******
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 24 .48 .7007
* BROWN-FORSYTHE 3, 32 .47 .7072
Q
UF MEAN SQUARE E VALUE TAIL PROBABILITY
Voo94ser3

Final Report
1-1729.005
TABLE GT5
ANALYSIS OF BODY WEIGHTS ON DAY 7
REF D6'PEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
27.000)
26.000)
25.000)
24.000)
23.000) *
22.000)* * ***
21.000)***** M***** M****** *****
20.000)M**** *** ** M****
19.000)* **
18.000)
17.000) *
16.000)
15.000)
14.000)
13.000)
12.000)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 20.492 20.642 20.883 20.317
STD.DEV. .667 1.395 .771 .741
R.E.S.D. .604 1.202 .804 .855
S. E. M. .192 .403 .223 .214
MAXIMUM 21.800 22.800 22.200 21.300
MINIMUM 19.200 17.200 19.700 19.300
SAMPLE SI ZE 12 12 12 12
AL L GROUPS COMBINED **********************R******** #*******#**********************
ANALYSIS OF VARIANCE TABLE
*
* SOURCE SUM OF SQUARES
* DF MEAN SQUARE F VALUE TAIL PROBABILITY
MEAN 20.583 * BETWEEN GROUPS 2.0750 3 .6917 .78 .5099
STD.DEV. .933 * WITHIN GROUPS 38.8717 44 .8834
R.E.S.D. .838 * p > 0.05;
S. E. M. .135 * TOTAL 40.9466 47 NOT SIGNII'ICANT
MAXIMUM 22.800 * A * # * * R * R * * * * * * R * * R * * * * R * R # * * * * R * # * * * * * * * * *
* * * * * k * * # # R * # # * * * # * * * # # * * * * R * * * # * A * * * * A * * * * * * * * * *
MINIMUM 17.200 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 44 1.15 .3394
SAMPLE SI ZE 48 * * R * * * * * * * * # * * * * * * * * * * * * * * * * * # * * * * * * R R * * * *
* * * * * * * * * * A * * * * * * * * * * * * * * * # A # A * * * A * * * * * * A * * k * A A * * *
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMEI) TO BE EQUAL
* WELCH
,
4
.13
3574
* BROWN-FORSYTHE 3, 30 .78 .5129
P.Ua94GBE3

Final Report
I-1729.005
TABLE GT6
ANALYSIS OF BODY WEIGHTS ON DAY 14
REF D6TEST D10TEST SIIAM
.......................+.......................+.......................+.......................+
VAR 5
EXCLUDED DIED DURING EXPOSURE
VALUES
MIDPOINTS
*
TABULATIONS AND COMPUTATIONS WHICH FOLLOW EXCLUDE VALUES LISTED ABOVE
23.200)
22.800)
22.400)
22.000)
21..600) * * *
21.200)** ** * *
20.800) * *** ** ***
20.400)M*** M* M M*
20.000)** ** *** *
*** **
19.600)*
19.200)*
*
*
18.800) *
18.400)
18.000)
17.600) *
17.200)
GROUP MEANS ARE DENOTED BY M'S IF
THEY COINCIDE WITH *'S,
N'S OTHERWISE
MEAN 20.450 20.425
STD.DEV. .683 1.139
R.E.S.D. .687 1.031
S. E. M. .197 .329
MAXIMUM 21.600 22.300
MINIMUM 19.300 17.700
SAMPLE SIZE 12 12 20.409
.742
.850
.224
21.700
19.600
11 20.308
.812
.882
.234
21.600
18.900
12
*******************************
ALL GROUPS COMBINED ANALYSIS OF VARIANCE TABLE *******************************
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 20.398 * BETWEEN GROUPS .1390 3 .0463 .06 .9796
STD.DEV. .838 * WITHIN GROUPS 32.1507 43 .7477
R.E.S.D. .834 * p > 0.05;
S. E. M. .122 * TOTAL 32.2898 46 NOT SIGNII'ICANT
***********************************R***************R******************************A*********
MAXIMUM 22.300
MINIMUM 17.700 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 43 .53 .6659
**********A*****************#**************************************************************k
SAMPLE SIZE 47
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 24 .07 .9749
*
OO91 BROWN-FORSYTHE 3, 37 .06 .97
93
'
1VpC3 ,

Final Report
I-1729.005
TABLE GT7
ANALYSIS OF BODY WEIGHTS ON DAY 21
REF D6TEST DIOTEST SHAM
.......................+.......................+.......................+.......................+
VAR 6
EXCLUDED DIED DURING EXPOSURE
VALUES
*
*
TABULATIONS AND COMPUTATIONS WHICH FOLLOW EXCLUDE VALUES LISTED ABOVE
MIDPOINTS
22.800)
22.500) *
22.200)* * **
21.900)** *** * *
21.600) *
21.300)** * *
21.000)M ** M* M*
20.700)*** M* *
20.400)* * *** ***
20.100)** * *
19.800) **
19.500)
19.200) *
18.900)
18.600)
1.8.300)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 21.000 20.733
STD.DEV. .659 1.033
R.E.S.D. .720 1.040
S. E. M. .190 .298
MAXIMUM 22.100 21.900
MINIMUM 20.200 18.600
SAMPLE SIZE 12 12 21.045
.674
.721
.203
22.200
20.100
11 21.100
.982
1.075
.296
22.600
19.900
11
*********RR********kR******RR*R
ALL GROUPS COMBINED ANALYSIS OF VARIANCE TABLE *******************************
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 20.965 * BETWEEN GROUPS .9304 3 .3101 .42 .7367
STD.DEV. .839 * WITHIN GROUPS 30.7139 42 .7313
R.E.S.D. .859 * p > 0.05;
S. E. M. .124 * TOTAL 31.6443 45 NOT SIGNIFICANT
******************************R*************************************************************
MAXIMUM 22.600
MINIMUM 18.600 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 42 1.20 .3203
******R************************************************f******#*****************************
SAMPLE SIZE 46
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO RF EQUAL
* WELCH 3, 23 .30 .8244
* BROWN-FORSYTHE 3, 36 .42 .7363
1-UOJf./be3

Final Report
1-1729.005
TABLE GT8
ANALYSIS OF BODY WEIGHTS ON DAY 28
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
VAR 7
EXCLUDED ANIMALS SACRIFICED FOR 3 WEEK ANALYSIS
VALUES
*** *** *** ***
TABULATIONS AND COMPUTATIONS WHICH FOLLOW EXCLUDE VALUES LISTED ABOVE
MIDPOINTS
23.400)
23.100)
22.800)
22.500) *
22.200) *
21.900) ** *
21.600)* * **
21.300) * *
21.000)** * M M
20.700)M* M ** **
20.400) ** ** ***
20.100) * **
19.800) *
19.500) * *
19.200)
18.900)
*'S,
N'S OTIIERWISE
MEAN 20.578 20.778
S9'D.DEV. .595 .845
R.E.S.D. .594 .890
S. E. M. .198 .282
MAXIMUM 21.600 22.100
MINIMUM 19.600 19.600
SAMPLE SIZE 9
ALL GROUPS COMBINED
MEAN 20.867
STD.DEV. .727
R.E.S.D. .727
S. E. M. .121
MAXIMUM 22.600
MINIMUM 19.600
SAMPLE SIZE 36
R00946eR
21.111 21.000
.777 .671
.847 .709
.2.59 .224
22.6C0 22.000
20.400 20.000
9 9 9
* * * * * * * * * * * M1 * * * * * * * * * * * * * * * * * * *
*
ANALYSIS OF VARIANCE 'PABLE
* * * k * * * * * * * * * * fr * * * * * * * * * * * * * * * *
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
* BETWEEN GROUPS 1.5200 3 .5067 .95 .4259
* WITHIN GROUPS 16.9800 32 .5306
* p > 0.05;
* TOTAL 18.5000 35 NOT SIGNIFICANT
***************************************k*************l.********************i.*****************
* LEVENE'S TEST FOR EQUAL VARIANCES 3, 32 .60 .6206
*****************************k**********#**********k****************************************
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 18
* BROWN-FORSYTHE 3, 30
1.05 .3929
.95 .4267

Final Report
1-1729.005
TABLE GT9
ANALYSIS OF BODY WEIGHTS ON DAY 35
REF D6TEST DIOTEST SHAM
............+ .......................+.......................+.......................+
VAR 8
EXCLUDED ANIMALS SACRIFICED FOR 3 WEEK ANALYSIS
VALUES
*** *** h** k**
MIDPOINTS
TABULATIONS AND COMPUTATIONS WHICH
FOLLOW
EXCLUDE VALUES
LISTED
ABOVE
23.400)
23.100)
22.800) *
22.500) *
22.200) *
21.900) * *
21.600)*** *
21.300)* M* *
21.000)N * ** N
20.700)** N *** *
20.400)*** ** ****
20.100) *k* *
19.800)
19.500) *
19.200)
18.900)
GROUP MEANS ARE DENOTED BY M'S IF
THEY COINCIDE WITH
*'S, N'S OTHERWISE
MEAN 20.933 20.678
STD.DEV. .539 .894
R.E.S.D. .640 .935 21.267
.684
.640 20.856
.695
.748
S. E. M. .180 .298
MAXIMUM 21.600 22.400
MINIMUM 20.300 19.600
SAMPLE SIZE' 9 9 .228
22.800
20.600
9 .232
22.200
20.100
9
ALL GROUPS COMBINED ***********************R*k***** *******************************
ANALYSIS OF VARIANCE TABLE
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 20.933 * BETWEEN GROUPS 1.6422 3 .5474 1.07 .3742
STD.DEV. .716 * WITHIN GROUPS 16.3178 32 .5099
R.E.S.D. .709 * p > 0.05;
S. E. M. .119 * TOTAL 17.9600 35 NOT SIGNIFICANT
MAXIMUM 22.800
***********************************k****************************R***************************
MINIMUM 19.600 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 32 .65 .5861
SAMPLE SIZE 36
***k*************************************************************************************k**
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO HE EQUAL
* WELCH 3, 18 .91 .4565
*
E;00946gE3 BROWN-FORSYTHE 3, 28 1.07 .3762

Final Report
1-1729.005
TABLE GT10
ANALYSIS OF BODY WEIGHTS ON DAY 42
VAR 9
EXCLUDED
VALUES
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
ANIMALS SACRIFICED FOR 3 WEEK ANALYSIS
* * *
TABULATIONS AND
MIDPOINTS
*** ***
COMPUTATIONS WHICH FOLLOW EXCLUDE VALUES
LISTED ABOVE
R##
24.300)
24.000)
23.700)
23.400) *
23.100) * *
22.800)* *
22.500)**
22.200)M* *
21.900)* * ** M
21.600)* M* N *****
21.300)** **# *
21.000) M*
20.700) *
20.400) * *
20.100) *
19.800)
GROUP MEANS ARE DENOTED BY
M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 22.089 21.500
STD.DEV. .540 1.099
R.E.S.D. .578 .857
S. E. M. .180 .366
MAXIMUM 22.900 24.000
MINIMUM 21.300 20.000
SAMPLE SIZE 9 9 21.567
1.005
1.073
.335
23.300
20.500
9 22.044
.577
.611
.192
23.100
21.500
9
**#*R*************R***R********
ALL GROUPS COMBINED ANALYSIS OF VARIANCE TABLE *******************************
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 21.800 * BETWEEN GROUPS 2.5889 3 .8630 1.21 .3202
STD.DEV. .851 * WITHIN GROUPS 22.7311 32 .7103
R.E.S.D. .745 * p > 0.05;
S. L'. M. .142 * TOTAL 25.3200 35 NOT SIGNIFICANT
***************#****#***********************#*****R#****************R***#*****#*************
MAXIMUM 24.000
MINIMUM 20.000 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 32 .92 .4417
**#**********#*******************i.******k****#**R*****R************************k*#**********
SAMPLE SIZE 36
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3 17 1.13 .3646
6L4946grj * BROWN-FORSYTHE ,
3, 24 1.21 .3258

Final Report
I-1729.005
Table GT11
Weight of Lung Tissue at Necropsy in Mice
Exposed to Cigarette Smoke for 6 Weeks
Group-Cigarette
Animal Number
Lung Weight (g)
1-Reference
1151
1152
1153 0.13
0.15
0.15
Mean + Stand. Dev. 0.14 + 0.01
2-D6
1163 0.13
1164 0.14
1165 0.17
Mean + Stand. Dev. 0.15 + 0.02
3-D10
1175 0.17
1176 0.15
1177 0.15
Mean + Stand. Dev. 0.16 + 0.01
4-Sham
1186 0.14
1188 0.12
1189 0.16
Mean + Stand. Dev.
0.14 + 0.02

Final Report
I-1729.005
Table GT12
Aryl Hydrocarbon Hydroxylase (AHH) Activity in Selected
Tissues of Mice Exposed to Cigarette Smoke for Six Weeksa
b
Tissue AHH Values + SD
Group Liver Lung Kidney
(pmol/min/mg protein)
----------------------------------------------------=-----------------
1-Ref 109.9 + 61.5 2.1 + 0.6 0.7 + 0.3
2-D6 80.0 + 62.6 0.9 + 0.8 1.0 + 0.3
3-D10 76.5 + 46.6 1.7 + 0.8 0.9 + 0.2
4-Sham 42.6 + 17.8 2.1 + 1.7 0.5 + 0.2
aMice were exposed daily (5 days/week) using the RSD1 exposure regimen
for 6 weeks. Animals were sacrificed 6 hours after initiation of the
last exposure to determine tissue levels of AHH.
bAHH units are pmoles 3-OH-BaP formed/min/mg microsomal protein at
37oC for 20 minutes. Means + standard deviations are given.

Final Report
1-1729.005
Abbreviations for Clinical Chemistry and Hematology
BUN - Blood urea nitrogen
CALC - Calcium
CREAT - Creatinine
LDH - Lactic dehydrogenase
ALKPHOS - Alkaline phosphatase
P04,PHOS - Phosphorous
SGOT - Serum-glutamic-oxaloacetic-transaminase
SGPT - Serum-glutamic-pyruvic-transaminase
TGA - Triglycerides
URICACID - Uric acid
AGRATIO - Albumin/globulin ratio
WBC - White blood cell
RBC - Red blood cell
HGB - Hemoglobin
HCT - Hematocrit
NEUTS - Segmented neutrophils
LYMPHS - Lymphocytes
MONO - Monocytes
RETCTN - Reticulocyte counts
CHOL - Cholesterol
TOTPROT - Total Protein
PMNCTN - Polymorphonuclear leukocyte counts

Final Report
I-1729.005
Abbreviations of BMDP Statistical Tables
STD. DEV. - Standard Deviation
R.E.S.D. - Robust Estimate of Standard Deviation
S.E.M. - Standard Error of the Mean
N.S. - Not Significant, p > 0.05

Final Report
1-1729.005
TABLE CCH1
CLINICAL CHEMISTRY FOR 3 WEEK SACRIFICE OF MICE
NO. LABEL CIG GLUCOSE CHOL TGA CREAT BUN URIC ACID TOT PROT ALBUMIN A/G RATIO
TYPE mg/dl mg/dl mg/dl mg/dl mg/dl mg/dl g/dl g/dl
----
-------- ---------- ---------- ---------- ---------- ---------- --------- --------- ---------- --- -
------ ----------
1 1145 REF 121.350 79.500 77.700 .320 30.500 4.050 4.700 2.900 1.611
2 1146 REF 188.350 80.300 69.900 .310 34 4.650 5 2.900 1.381
3 1147 REF 137.300 91.100 66.700 .350 30.750 3.950 4.900 3 1.579
4 1157 D6 156.200 69.900 81.100 .380 30.250 3.350 4.700 2.700 1.350
5 1158 D6 139.200 86.300 87.200 .390 28.450 2.450 4.900 2.900 1.450
6 1159 06 158.600 87 73.300 .440 32.900 4.300 5 3 1.500
7 1169 D10 137.200 87.400 52.500 .400 31.750 4.050 5.200 3 1.364
8 1170 D10 135.350 81.400 55.700 .320 31.350 4.200 4.700 2.900 1.611
9 1181 SHAM 168.400 92.600 58.400 .170 20.500 3.850 5.100 3 1.429
10 1182 SHAM 152.100 84.700 47.400 .110 22.200 4.300 5 3.100 1.632
S FQ9&(;&.7

Final Report
1-1729.005
TA13LE CC112
CL.INICAL CIIh;MIS'PRY FON 3 WEEK SACRI['ICN Oh' MICE
NO. LABEL LU1I
U/1 ALKPIIOS
U/1 SGP'1'
U/1 SGOT
U/1 CAL.:IUM
my/c11 PHOS
my/dl
----
1 --------
1145 ----------
394 ----------
71 ----------
45 ----------
122 ----------
10.000 ----------
6.700
2 1146 300 66 38 213 9.896 7.300
3 1147 215 62 32 124 9.063 7.900
4 1157 183 71 48 147 9.583 6.400
5 1158 201 65 40 QNS`' 10.208 7.100
6 1159 281 78 51 137 10.000 7.200
7 1.169 264 64 39 161 9.583 7.800
8 1170 246 60 29 QNS 9.479 7.300
9 1181 121 66 35 92 9.375 6.900
10 1182 222 50 45 QNS 8.040 6
`'QNS = QIJANTITY NCYI' SUl'Ftc;[RN'I' i'clk ANALYSTS.
ytoy4sea

Final Report
I-1729.005
TABLE CCti3
IIEMATOLOGY FOR 3 WEEK SACRIFICE OF MICE
NO. LABEL CIG
'1'YPE WBC
thousand RBC IIGB
million y% I1C'I' NEUTS LYMPIIS MONOCYTE
$ $ $ $ RETCTN
$ PLATELET
---- -------- -- -------- ---------- ---------- ----------
1 1145 REF 5.400 9.570 15.800 47.600 31 68 1 .800 ADEQ
2 1146 RL'F 5.400 10.790 17.800 52.300 41 57 1 .600 ADEQ
3 1147 REF 3.700 9.090 15.100 43.900 32 67 1 1.400 ADEQ
4 1157 D6 4.900 9.920 16 47.900 26 70 2 0 1.500 ADEQ
5 1158 D6 4 9.100 14.700 44.600 28 72 NR 1.500 ADEQ
6 1159 D6 5.600 10.130 16.600 49.400 23 74 NR .800 ADEQ
7 1169 D10 4.300 9.270 14.600 44.900 33 64 1 1.100 A[)EQ
8 1170 D10 6.100 9.660 16.500 47.900 21 76 NR .900 ADEQ
9 1181 SNAM 1.600 8.870 14.700 43.300 38 62 NR 1.600 ADEQ
10 1182 SIiAM 2.300 9.760 15.500 47.500 38 62 NR 1.500 ADEQ
u
N 12 = NONE RL:L'OR'I'C:D OR OBSIIIiVP7D.
4toyj,sae

Final Report
1-1729.005
TABLE CCH4
HEMATOLOGY FOR 3 WEEK SACRIFICE OF MICE
NO. LABEL PMNCTN EOSIN
$
------
1
2 1145
1146 MODERATE
MODERATE a
NR 1.0
3 1147 MODERATE NR a
4 1157 MODERATE 2.0
5 1158 MODERATE NRa
6 1159 MODERATE 3.0
7 1169 MODERATE 2.0
8 1170 MODERATE 3.0
9 1181 MODERATE NR a
10 1182 MODERATE NRa
a
NOT REPORTED OR OBSERVED.
Nio94sea

Final Report
1-1729.005
TABLE CCH5
HISTOGRAM OF GLUCOSE
ANALYSIS OF GLUCOSE VALUES AFTER ; WEEKS EXPOSURE
REF D6TEST D10TEST SHAM
......................... .......................................................................
.....+
MIDPOINTS
200.000)
190.000)
*
180.000)
170.000)
160.000) **
150.000)N N
140.000)* * M*
130.000)
120.000) *
110.000)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 149.000
STD.DEV. 34.999
R.E.S.D. 40.268
S. E. M. 20.207
MAXIMUM 188.350
MINIMUM 121.350
SAMPLE SIZE 3
ALL GROUPS COMBINED
MEAN 149.405
STD.DEV. 19.436
R.E.S.D. 16.001
S. E. M. 6.146
MAXIMUM 188.350
MINIMUM 121.350
SAMPLE SIZE 10
151.333 136.275
10.576 1.308
12.416 1.640
6.106 .925
158.600 137.200
139.200 135.350
3 2
k**********k******R***RkR******
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH '
* BROWN-FORSYTHE
*
N
*
160.250
11.526
14.445
8.150
168.400
152.100
2
ANALYSIS OF VARIANCE TABLE
*******R*****k*****************
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
* BETWEEN GROUPS 591.6689 3 197.2230 .42 .7446
* WITHIN GROUPS 2808.0981 6 468.0163
* p > 0.05;
* TOTAL 3399.7666 9 NOT SIGNIFICANT
***********************************************Rk********************R******k*****k*****R***
* LEVENE'S TEST FOR EQUAL VARIANCES 3, 6 4.50 .0559
**RR**********************************R****************************************R************
3, 3 3.20 .1823
3, 3 .57 .6736
G10y46B3

Final Report
1-1729.005
TABLE CCH6
HISTOGRAM OF cHOL ANALYSIS OF CHOLESTEROL AFTER 3 WEEKS EXPOSURE
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
96.000)
93.000)
*
90.000)* N
87.000)
84.000)N
*
*
*
N
*
81.000)* N
78.000) *
75.000)
72.000)
69.000)
*
*
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 83.633 81.067 84.400 88.650
STD.DEV. 6.479 9.677 4.243 5.586
R.E.S.D. 7.641 11.427 5.317 7.001
S. E. M. 3.740 5.587 3.000 3.950
MAXIMUM 91.100 87.000 87.400 92.600
MINIMUM 79.500 69.900 81.400 84.700
SAMPLE SIZE 3 3 2 2
* i. * * *
*R****R#*********************** ANALYSIS OF VARIANCE TABLE
ALL GROUPS COMBINED * * * * * * R * * k * * * * * * * * A k * * * * * *
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
MEAN 84.020 * BETWEEN GROUPS 69.7777 3 23.2592 .44 .7356
STD.DEV. 6.585 * WITHIN GROUPS 320.4386 6 53.4064
R.E.S.D. 6.760 * p > 0.05;
S. E. M. 2.082 * TOTAL 390.2163 9 NOT SIGNIFICANT
*****#*****R******************R*************k*******R***********************************k***
MAXIMUM 92.600
MINIMUM 69.900 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 6 1.83 .2426
***************R*******************A*******************R**#*************************k*******
SAMPLE SIZE 10
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 3 .35 .7932
* BROWN-FORSYTHE 3, 5 .52 .6871
ozos4sea

TABLE CCH7
ANALYSIS OF TRIGLYCERIDES AFTER 3 WEEKS EXPOSURE
IIIS'I'OGRAM OL' TGA
Final Report
1-1729.005
REF D6TEST D10'I'h:ST S[IAM
.......................4 ....................... i....................... -I................
........t
M1DPOIN'/'S
90.000)
85.000)
80.000)*
75.000)
70.000) M
65.000)*
60.000)
*
M
*
*
55.000) M N
50.000)
45.000)
*
dGROUP MEANS ARE DENO'PEI) BY M' S IF THEY COINCIDE WITII *'S , N'S OTIIERWISE
MEAN 71
433' a,c
8
1),
°
. 0.533 54.100 52.900
STI"1.Ij EV. 5.658 6.967 2.263 7.778
R,E.S.D. 6.413 7.402 2.836 9.748
S. E. M. 3.267 4.023 1.600 5.500
MAXIMUM 77.700 87.200 55.700 58.400
MINIMUM 66.700 73.300 52.500 47.400
SAMPLE SIZE 3 3 2 2
ALL GROUPS COMI3INE1) *****k*#****k*#**#k*#***k*kk*** ANALYSIS OE' VARIANCE 'I'AU[,E
*******k***#*k*#k*Akkk**k****#k
k
* SOURCE SUM OF SQUARES DE MEAN SOUARE F VALUE TAIL PROBABILITY
*
MEAN 66.990 * BEITWEEN GROUPS 1338.8557 3 446.2852 11.81 .0063
STD.DEV.
E 13.189 *
* 4'ITIIIN GROUPS 226.7333 6 37.7889
R.
.S.U. 5.443
S. E. M. 4.171 * TOTAL 1565.5889 9 05
1) ` 0
MAXIMUM 87.200 k * # # # * * * k # # * * k * k * * * * * # k * * # k * * k * k * * * k k k * * * * #
* # * * # * * * k * * * * k # * A * * * * # # # * * * # * * k * .
* * * k k * * k # * * * # * # * fi
MINIMUM 47.400 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 6 .92 .4846
SAMPLE SI'LE 10 k # * # # * * # * * # * * * * * k * * * # * * * # k # * * * * k * * * * * # k * * *
* * * k * * * * * k * * A * k * F * i. * * # * # * * * * * * * * * A k * * * * k * * k k # * * * * *
* ONE-WAY ANALYSIS OE' VARIANCE
* TEST S'I'ATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EpUAL
* WELCH 3, 3 12.17 .0347
* BRUWN-E'ORSY'1'[iE 3, 4 12.30 .0173
tzos4sse
aSIGNIFICAN'1'LY D1FE'13R1'N'I' PROM 5[IAM CON9'ROL, S'PIIDI:N'I'1'LGIi RANG!: '['I:ST, p< 0.()5
bSIGNIE'ICANTLY DIFFLRPIN'C FROM REFERENCE C1GAR1;'Nl'I:, i'!'[1DiN'1'l'l.E[) RANGE TIi 9', p 0,05,
cS1GN[I'ICANTLY DI1'NI:REN'P FROM OTHER TEST CIG,IRE1'TL', S'I'UI)I;N'I'I'LI,D RANGI1 TEST,
p`< 0,05.

Final Report
I-1729.005
tl I S'l'OGRAM 01' CItEIA'1'
TABLE CCH8
ANALYSIS OF CREATININE AFTER 3 WEEKS EXPOSURE
kEF 1)6'I'ES'I' D10'I'I:S'1' SIIAM
............................................... i.............................. ..................
MIDPOIN'PS
.500)
.450)
.400)
.350) M
.300)**
.250)
.200)
.150)
.100)
.050)
"GROUP MEANS
ARE DIiNO`I'ED BY M'S IF
*
M*
*
N
*
MEAN .32V'
S'1'D.DEV. .021
R.E.S.D. .024
S. E. M. .012
MAXIMUM .350
MINIMUM .310
SAMPI,E SIZE 3
AL,L GROIIPS COMBINED
MEAN .319
STD.DEV. .104
R.E.S.D. .034
S. E. M. .033
MAXIMUM .440
MINIMUM .110
SAMPLE SIZE 10
M
*
'f'HEY
COINCIDE WITtI *'S, N'S
OTIIE]RWIShI
403 ~ . 360 a
.032 .057
.038 .071
.019 .040
.440 .400
.380 .320
3 2
* * * k * A * * * * * * * * * * * * * * * * * * * * k * * * *
ANALYSIS
* * * /. * * * * * A * * * * * * * * k * * * * * * * * * * k *
*
* SOURCE SUM OF SQUARES DE MEAN S~,)IIARE F VALUE TAII, PROBABILITY
*
* BETWEEN GROUPS .0890 3 .0297 22.43 .0012
* WITHIN GROUPS .0079 6 .0013
*
* TOTAL .0969 9 1) < 0.05
* A * * * * * * * * * * * * * * A * * * * A * * * A * * * * * * * * k * * * * * * A * l. * * * * * *
* * * * * * * * * * * * * * * * A * * * * * * * * * A * * R A * * * * * * * * * A *
* LEVENE'S TEST FOR EQUAL VARIANCES 3, 6 3.66 .0828
* * * * * * * * * * * k * * * * * A * * * * * * * * * * * * * A * * * * * * k * * * * * * k * * * *
* * * * A * * * A R A k * * * * * * * * * * * k * A A A A A * * * * * * * * * * A *
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STA'I'ISTICS FOR WITIIIN-GROI)P
* VARIANCES NO'I' ASSUMED '1'0 BE EQUAL
* WELCII 3, 2
* BROWN-PORSY't'lIE 3, 3
12.10 .0773
17.70 .0207
a 5IGN1l'lt'AN'I'I,Y UL1'NI:RI-N'I' f'lt(1M SunM CONTRC)I,, tPl'lID1:N'1'IZP,I) kAN(J; < 0.05.
zzo94seR

Final Report
1-1729.005
HISTOGRAM ON 6UN
12E;E'
TABLE CCH9
ANALYSIS OF BLOOD UREA NITROGEN AFTER 3 WEEKS EXPOSURE
D 6'1' E S'1' D 1. 0'I' E S'I' S 11 A M
....................... +...............................................
MIDPOIN'I'S t..................... ..+
39.000)
36
000)
.
33.000)*
30.000)N
27.000)**
#
M* N
24.000)
21.000)
18.000)
15.000)
12.000)
'GROUP MEANS ARE DENOTED BY
'S *
F *
*
HEY COINCIDE WITU *'S, N'S OTHERWISE
*
M
*
MEAN 29.867a 26.367a 25.567 a 17.667
STD.DEV. 3.848 1.856 3.580 2.281
R.E.S.D. 4.537 1.978 4.025 2.524
S. E. M. 2.221 1.071 2.067 1.317
MAXIMUM 34.300 28.300 29.500 19.700
MINIMUM 27.400 24.600 22.500 15.200
SAMPLE SIZE 3 3 3 3
ALL GROUPS COMBINED *************************R****#
ANALYSIS Oh * * * # * k * * * * * * * * * * * * * k * * * k k * A * * * *
VARIANCE TABLE
x
* SOURCE SUM OE' SQUARES 1)E MEAN SQUARE F VALUE 'fAIL
k PROBABILITY
MEAN 24.867 * BETWEEN GROUPS 238.7401 3 79.5800 8.78 .0065
STD.DEV. 5.319 * WITHIN GROUPS 72.5267 8 9.0658
R.E.S.D. 2.785 *
S. E. M. 1.536 * TOTAL 311.2667 11 p< 0.05
MAXIMUM 34.300 * * * * R * * * * * * * * # * * * * * * * * * k * * * * * * * * * * M * * * * k * * *
* * k # * * * * * * A * * * * k * * * A k * * * A * * # * * * * * * * * * * * * * * * * * * * * *
MINIMUM 15.200 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 8 1.19 .3746
SAMPLE S1 ZE 12 * * * * R R * * * * * * * * * * * * * * * * * * k * # * * * * * * * * * * # * * * *
* * * A * * * * * * R k * k * * * * * * k * * * M # * # # * # k * * k * * * * * * * k * * # * * k #
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITUIN-GROUP
* VARIANCES NO'I' ASSUMED TO BE EQUAL
* WELCII 3, 4 9.04
0296
* BROWN-E'ORSY'PUE 3, 6 8.78 .0130
dSIC;NIFICAfITLY DIFI'ERI:N'P I'ROM SUAM CONTROL, S'TUDI:N'I'I'LL'f) kAN(;1: 'I'RS'I', 1< 0.05.
EZ03G6e9

Final Report
I-1729.005
TABLE CCH10
HISTOGRAM OF URICACID
ANALYSIS OF URIC-ACID AFTER 3 WEEKS EXPOSURE
REF D6TEST DIOTEST SHAM
.................+.......................+.......................+.......................+
MIDPOINTS
4.800)
4.500) *
4.200)N * M M
3.900)** * *
3.600)
3.300) M
3.000)
2.700)
2.400) *
2.100)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 4.217 3.367
STD.DEV. .379 .925
R.E.S.D. .443 .955
S. E. M. .219 .534
MAXIMUM 4.650 4.300
MINIMUM 3.950 2.450
SAMPLE SIZE 3 3 4.125
.106
.133
.075
4.200
4.050
2 4.075
.318
.399
.225
4.300
3.850
2
****R*t*****A*********R********
ALL GROUPS COMBINED ANALYSIS OF VARIANCE TABLE * * k * * * * * M * * * * * * * * A A * A * * * * * *
* * * *
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 3.915 * BETWEEN GROUPS 1.3144 3 .4381 1.25 .3733
STD.DEV. .617 * WITHIN GROUPS 2.1108 6 .3518
R.E.S.D. .440 * p > 0.05;
S. E. M. .195 * TOTAL 3.4253 9 NOT SIGNIFICANT
*****R*****i.f***************i**********A**********************************A***********M****k
MAXIMUM 4.650
MINIMUM 2.450 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 6 1.41 .3289
***************************************************************************A*****x**********
SAMPLE SIZE 10
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 3 .50 .7056
* BROWN-FORSYTHE 3, 3 1.67 .3428
Vzousetq

Final Report
I-1729.005
TABLE CCH11
HISTOGRAM OF TOTPROT
ANALYSIS OF TOTAL PROTEIN AFTER 3 WEEKS EXPOSURE
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
5.250)
5.180)
5.110)
5.040)
*
4.970)* * N
4.900)M M
4.830)
4.760)
4.690)*
4.620)
*
*
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 4.867
STD.DEV. .153
R.E.S.D. .171
S. E. M. .088
MAXIMUM 5.000
MINIMUM 4.700
SAMPLE SIZE 3
ALL GROUPS COMBINED
MEAN 4.920
STD.DEV. .175
R.E.S.D. .167
S. E. M. .055
MAXIMUM 5.200
MINIMUM 4.700
SAMPLE SIZE 10
4.867 4.950
.153 .354
.171 .443
.088 .250
5.000 5.200
4.700 4.700
3 2
********R**********************
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH
* BROWN-FORSYTHE
*
N
*
5.050
.071
.089
.050
5.100
5.000
2
ANALYSIS OF VARIANCE TABLE
* * * * * * * * l. * * * * * * * * * * * * * * * * * * * * * *
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
* BETWEEN GROUPS .0527 3 .0176 .47 .7131
* WITHIN GROUPS .2233 6 .0372
* p > 0.05;
* TOTAL .2760 9 NOT SIGNIFICANT
*********!R********************Ie******************************it*******k*********1c***********
* LEVENE'S TEST FOR EQUAL VARIANCES 3, 6 4.53 .0551
********************************************************************************************
3, 3 1.19 .4439
3, 2 .39 .7783
~zos,~se~

Final Report
I-1729.005
TABLE CCH12
IIISTOGRAM OF' ALBUMIN
ANALYSIS OF ALBUMIN AFTER 3 WEEKS EXPOSURE
REF D6TEST D10TEST SHAM
.......................................................... ................+
MIDPOINTS
3.220)
3.150)
3.080) M
3.010) * * * *
2.940) N N
2.870)** M *
2.800)
2.730) *
2.660)
2.590)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 2.933 2.867
STD.DEV. .058 .153
R.E.S.D. .068 .171
S. E. M. .033 .088
MAXIMUM 3.000 3.000
MINIMUM 2.900 2.700
SAMPLE SIZE 3 3 2.950
.071
.089
.050
3.000
2.900
2 3.050
.071
.089
.050
3.100
3.000
2
ALL GROUPS COMBINED ****R*k***#***R*k**********#**R ***************R***************
ANALYSIS OF VARIANCE TABLE
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
MEAN R
2.940 *
BETWEEN GROUPS
.0407
3
.0136
1.28
.3621
STD.DEV.
R.E.S.D. .107 *
.088 * WITHIN GROUPS .0633 6 .0106 p> 0.05;
S. E. M. .034 * TOTAL .1040 9 NOT SIGNIFICANT
MAXIMUM 3.100
k*R*******#*******************************************************************************hR
MINIMUM 2.700 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 6 1.64 .2766
SAMPLE SIZE 10
*#R*#**k*********#*R**##*#*************#****#!*R***********#***********************k****#***
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 3 1.14 .4592
* BROWN-FORSYTHE 3, 4 1.52 .3376
szo94set3

Final Report
1-1729.005
TABLE CCH13
HISTOGRAM OF AGRATIO
ANALYSIS OF A/G RATIO AFTER 3 WEEKS EXPOSURE
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
1.680)
1.640) *
1.600) * *
1.560) *
1.520)N N
1.480) * N
1.440) M
1.400)*
1.360)
1.320)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S , N'S OTHERWISE
MEAN 1.524 1.433
STD.DEV. .125 .076
R.E.S.D. .146 .085
S. E. M. .072 .044
MAXIMUM 1.611 1.500
MINIMUM 1.381 1.350
SAMPLE SIZE 3 3 1.487
.175
.219
.124
1.611
1.364
2 1.530
.144
.180
.102
1.632
1.429
2
AL[. GROUPS COMBINED ******************************* ANALYSIS OF VARIANCE TABLE
*******************************
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 1.491 * BETWEEN GROUPS .0163 3 .0054 .35 .7937
STD.DEV. .111 * WITHIN GROUPS .0940 6 .0157
R.E.S.D. .119 * p > 0.05;
S. E. M. .035 * TOTAL .1102 9 NO'I' SIGNIFICANT
MAXIMUM 1.632
***Rk****~F********************~F************#**h***R*k*fr**ir*8.F*******i4***********RM*kR*******
MINIMUM 1.350 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 6 1.96 .2221
SAMPLE SIZE 10
*****1F*************************************fi***************it***********************1x********
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 2 .35 .7985
* BROWN-FORSYTHE 3, 3 .29 .8314
LzOyL6B~q

Final Report
I-1729.005
TABLE CCH14
HISTOGRAM OF LDH
ANALYSIS OF LACTIC DEHYDROGENASE AFTER 3 WEEKS EXPOSURE
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
440.000)
400.000)*
360.000)
320.000)N
280.000)* * *
240.000) N M *
200.000)* **
160.000) N
120.000) *
80.000)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S , N'S OTHERWISE
MEAN 303.000 221.667
STD.DEV. 89.538 52.166
R.E.S.D. 93.123 60.717
S. E. M. 51.695 30.118
MAXIMUM 394.000 281.000
MINIMUM 215.000 183.000
SAMPLE SIZE 3 3 255.000
12.728
15.952
9.000
264.000
246.000
2 171.500
71.418
89.509
50.500
222.000
121.000
2
ALL GROUPS COMBINED ******************************* *******************************
ANALYSIS OF VARIANCE TABLE
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 242.700 * BETWEEN GROUPS 22676.9336 3 7558.9775 1.70 .2662
STD.DEV. 74.099 * WITHIN GROUPS 26739.1667 6 4456.5278
R.E.S.D. 55.443 * p > 0.051
S. E. M. 23.432 * TOTAL 49416.0938 9 NOT S1GN1F1CANT
MAXIMUM 394.000
******************************************************************************k**k**********
MINIMUM 121.000 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 6 1.18 .3933
SAMPLE SIZE 10
****k******************************************************************i.*************fi******
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 3 1.03 .4899
* BROWN-FORSYTHE 3, 4 1.93 .2659
Rzas4sea

Final Report
1-1729.005
TABLE CCH15
HISTOGRAM OF ALKPHOS
ANALYSIS OF ALKALINE PHOSPHATASE AFTER 3 WEEKS EXPOSURE
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
80.000)
76.000)
72.000)*
68.000)N
64.000)*
60.000)*
56.000)
52.000)
48.000)
44.000)
GROUP MEANS ARE
DENOTED
BY
M'S
*
M
*
*
M
*
N
*
IF
THEY
COINCIDE WITH *'S, N'S OTHERWISE
MEAN 66.333 71.333 62.000 58.000
STD.DEV. 4.509 6.506 2.828 11.314
R.E.S.D. 4.776 6.822 3.545 14.180
S. E. M. 2.603 3.756 2.000 8.000
MAXIMUM 71.000 78.000 64.000 66.000
MINIMUM 62.000 65.000 60.000 50.000
SAMPLE SIZE 3 3 2 2
ALL GROUPS
COMBINED *k**********A******************
ANALYSIS * *
OF VARIANCE TABLE * * k * * * * * k A * * * * * k * * * * * * * k k * * * *
A
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE 'PAIL PROBABILITY
*
MEAN 65.300 * BETWEEN GROUPS 240.7667 3 80.2556 1.84 .2400
STD.DEV. 7.469 * WITHIN GROUPS 261.3333 6 43.5556
R.E.S.D. 5.637 * p > 0.05;
S. E. M. 2.362 * TOTAL 502.1000 9 NOT SIGNIFICANT
********A*#***************************A********************************k********************
MAXIMUM 78.000
MINIMUM 50.000 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 6 2.28 .1793
********************k******A***********A****************************M******AR*k*************
SAMPLE SIZE 10
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 3 1.36 .4026
* BROWN-FORSYTHE 3, 2 1.58 .4107
f,zoy4sea

Final Report
1-1729.005
TABLE CCH16
HISTOGRAM OF SGPT
ANALYSIS OF SGPT AFTER 3 WEEKS EXPOSURE
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
54.000)
51.000) *
48.000) *
45.000)* N *
42.000)
39.000)M * N
36.000) *
33.000) * N
30.000) *
27.000)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 38.333 46.333
STD.DEV. 6.506 5.686
R.E.S.D. 6.822 6.481
S. E. M. 3.756 3.283
MAXIMUM 45.000 51.000
MINIMUM 32.000 40.000
SAMPLE SIZE 3 3 34.000
7.071
8.862
5.000
39.000
29.000
2 40.000
7.071
8.862
5.000
45.000
35.000
2
ALL GROUPS COMBINED ******************************* ANALYSIS * * * * *
OF VARIANCE TABLE * * * * * * * * * * * * * * * * * * * * * * * * * *
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL. PROBABILITY
*
MEAN 40.200 * BETWEEN GROUPS 200.2667 3 66.7556 1.61 .2840
STD.DEV. 7.068 * WITHIN GROUPS 249.3333 6 41.5556
R.E.S.D. 6.077 * P > 0.05;
S. E. M. 2.235 * TOTAL 449.6000 9 NOT SIGNIFICANT
*******************************k******************************************************w*****
MAXIMUM 51.000
MINIMUM 29.000 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 6 .06 .9778
*********************A********************************A*************************************
SAMPLE SIZE 10
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 3 1.15 .4557
* BROWN-FORSYTHE 3, 4 1.51 .3399
UE09L6gR

Final Report
1-1729.005
TABLE CCH17
ANALYSIS OF SGOT AFTER 3 WEEKS EXPOSURE
HISTOGRAM OF SGOT
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
VAR 16
EXCLUDED
VALUES
QUANTITY NOT SUFFICIENT FOR ANALYSIS
* * *
MIDPOINTS
240.000) TABULATIONS AND COMPU;ATIONS WHICH FOLLOW EXCLUDE VALUES LISTED ABOVE
220
0
*
0
.
)
0
200.000)
180.000)
160.000)N M
140.000) M*
120.000)**
100.000) M
80.000)
60.000)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 153.000 142.000
STD.DEV. 51.971 7.071
R.E.S.D. 61.400 8.862
S. E. M. 30.006 5.000
MAXIMUM 213.000 147.000
MINIMUM 122.000 137.000
SAMPLE SIZE 3 2 161.000
.000
.000
.000
161.000
161.000
1 92.000
.000
.000
.000
92.000
92.000
1
********k**********************
ALL GROUPS COMBINED
ANALYSIS OF VARIANCE TABLE R******************************
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 142.286 * BETWEEN GROUPS 3223.4287 3 1074.4763 .59 .6617
STD.DEV. 38.025 * WITHIN GROUPS 5452.0000 3 1817.3333
R.E.S.D. 25.141 * p > 0.05;
S. E. M. 14.372 * TOTAL 8675.4277 6 NOT SIGNIFICANT
*************************k******M****k**********************k*****k*************************
MAXIMUM 213.000
MINIMUM 92.000 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 3 4.05 .1405
**************k*********************k*****R*****A******k***A****k****k********R*************
SAMPLE SIZE 7
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 11 .04 .9893
* BROWN-FORSYTHE 3, 2 2.04 .3455
I(:Q9468R

Final Report
I-1729.005
TABLE CCH18
HISTOGRAM OF CALCIUM
ANALYSIS OF CALCIUM AFTER 3 WEEKS EXPOSURE
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
10.400)
10.200) *
10.000)* M
9.800) *
9.600) N * M
9.400) * *
9.200)
9.000) * N
8.800)
8.600) *
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 9.653 9.931
STD.DEV. .514 .318
R.E.S.D. .604 .355
S. E. M. .297 .184
MAXIMUM 10.000 10.208
MINIMUM 9.063 9.583
SAMPLE SIZE 3 3 9.531
.074
.092
.052
9.583
9.479
2 9.010
.516
.646
.365
9.375
8.646
2
***R*#*************************
ALL GROUPS COMBINED ANALYSIS * * * #
OF VARIANCE TABLE * * k w * * * * * * * * * * * * * k * k k * * * * * *
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 9.583 * BETWEEN GROUPS 1.0381 3 .3460 2.07 .2054
STD.DEV. .476 * WITHIN GROUPS 1.0019 6 .1670
R.E.S.D. .358 * p > 0.05
S. E. M. .151 * TOTAL 2.0399 9 NOT SIGNIFICANT
***********************************~F*************************************R**#R**************
MAXIMUM 10.208
MINIMUM 8.646 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 6 3.10 .1108
***************************************************#************************.***************
SAMPLE SIZE 10
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 3 1.49 .3750
* BROWN-FORSYTHE 3, 3 2.20 .2675
v(:Q9z1b&R

Final Report
I-1729.005
TABLE CCH19
HISTOGRAM OF PHOS
ANALYSIS OF PHOSPHORUS AFTER 3 WEEKS EXPOSURE
REF D6TEST D10TEST SHAM
....................... +........................................................................
.......+
MIDPOINTS
8.400)
8.100)
7.800)* *
7.500) N
7.200)M ** *
6.900) N *
6.600)*
6.300) * N
6.000) *
5.700)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S , N'S OTHERWISE
MEAN 7.300 6.900 7.550 6.450
STD.DEV. .600 .436 .354 .636
R.E.S.D. .614 .512 .443 .798
S. E. M. .346 .252 .250 .450
MAXIMUM 7.900 7.200 7.800 6.900
MINIMUM 6.700 6.400 7.300 6.000
SAMPLE SIZE 3 3 2 2
ALL GROUPS COMBINED #*#R*R*R*****R*R*#R******R**RRR ANALYSIS OF VARIANCE TABLE
******************************R
*
" SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 7.060 * BETWEEN GROUPS 1.4740 3 .4913 1.81 .2458
STD.DEV. .587 * WITHIN GROUPS 1.6300 6 .2717
R.E.S.D. .476 * p > 0.05;
S. E. M. .186 * TOTAL 3.1040 9 NOT SIGNIFICANT
MAXIMUM 7.900
******R*****A************#*R***************#**RR****A****#**********R***k*******************
MINIMUM 6.000 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 6 .33 .8043
SAMPLE SIZE 10
*****R*R**R*R**R*R**R*R*******RR*R****R*#k**#*****##*********R****R*********k*#R****#*******
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 3 1.40 .3949
* BROWN-FORSYTHE 3, 4 1.82 .2831
f3:Q9F.t6g d

Final Report
1-1729.005
TABLE CCH2O
ANALYSIS OF WHITE BLOOD CELL COUNTS AFTER 3 WEEKS EXPOSURE
IIIS'L'OGRAM OF WBC
RP:L'
D6'PES'I' UlOTEST SIIAM
.......... ..................................... /....................... i........................
1-
MI1)POINTS
9.000)
8.000)
7.000)
6.000)
5.000) M*
4.000) *
3.000)
2.000)
1.000)
.000)
aGRUUP MEANS
E DENOTED
Y
S
*
M
*
L,
IEY COINCIDE WITH
*
N
*
'S,
S
IIERWISE
*
MEAN 4.833 a 4.833a 5.200° 1.950
STD.DEV. .981 .802 1.273 .495
R.E.S.D. 1.160 .853 1.595 .620
S. E. M. .567 .463 .900 .350
MAXIMUM 5.400 5.600 6.100 2.300
MINIMUM 3.700 4.000 4.300 1.600
SAMPLE SIZE 3 3 2 2
* * *
ALL GROUPS COMBINED * * * * * * k * * * * * * * * * A * * * * * * * * * * * * * * * * * * * * * * *
* * *
ANALYSIS OF VARIANCE TABLE * * * * * * * * * * * * * * * *
*
* SOURCE SUM OF SQUARES DP MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 4.330 * BETWEEN GROUPS 14.3627 3 4.7876 5.66 .0349
STD.DEV. 1.470 * WITIIIN GROUPS 5.0783 6 .8464
R.E.S.D. .850 *
S. E. M. .465 * TOTAL 19.4410 9 1' _ 0.05
* * *
MAXIMUM 6.100 * M * * * * * * * * * * * * * * A * * * * * * * * * * * k * * * * * * * * * * k # A A
* * R * A * A * * * # * * * # # k * * h * * h h A R * * * # * * * * R * * * * * * * * * * *
MINIMUM 1.600 * LEVENE'S TEST FOR EQUAI. VARIANCES 3, 6 1.21 .3664
* * *
SAMPLE SIZE 10 * * * * * * * * * * * * A * * * * * * * * * A * A * k * * * * * * * A * * * * * * * *
* * * R A * * * A * * h ir * A A A A * * A A h * * * A * * * * * F A * * * * * * h * A * * *
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITIIIN-GROUP
* VARIANCES NOT ASSUMEI) TO BE EQLIAL
* WELC11 3, 3 8.43 .0567
* BROl9N-FORSYTIIE 3, 3 5.49 .0978
a
ti1GN11'7C:A21'I'LY DIPI'I':RI:NT l'ROM :iIIAM CON'PI2OL, :iTUUI:N'I`I'/,f;l) RAN('.I: 0.0')
YcO9l.,IGBC/

Final Report
1-1729.005
TABLE CCH21
ANALYSIS OF RED BLOOD CELL COUNTS AFTER 3 WEEKS EXPOSURE
HISTOGRAM OF RBC
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
11.100)
10.800) *
10.500)
10.200) *
9 .900) N * *
9.600)* N M
9.300) * N
9.000)* * *
8.700)
8.400)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 9.817 9.717
STD.DEV. .876 .544
R.E.S.D. .996 .631
S. E. M. .506 .314
MAXIMUM 10.790 10.130
MINIMUM 9.090 9.100 9.465
.276
.346
.195
9.660
9.270 9.315
.629
.789
.445
9.760
8.870
SAMPLE SIZE 3 3 2 2
******************************* ********************k**********
ALL GROUPS COMBINED ANALYSIS OF VARIANCE TABLE
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 9.616 * BETWEEN GROUPS .3780 3 .1260 .29 .8310
STD.DEV. .575 * WITHIN GROUPS 2.6008 6 .4335 p> 0.05;
R.E.S.D. .589
S. E. M. .182 *
TOTAL
2.9788
9
NOT SIGNIFICANT
************R**********k************iF*******************************************************
MAXIMUM 10.790
MINIMUM 8.870 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 6 1.41 .3282
*******k************************************************************************************
SAMPLE SIZE 10
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 3 .23 .8681
* BROWN-FORSYTHE 3, 5 .34 .8004
sEOyz,sea

Final Report
1-1729.005
TABLE CCH22
ANALYSIS OF HEMOGLOBIN AFTER 3 WEEKS EXPOSURE
HISTOGRAM OF HGB
REF D6TEST D10TEST SHAM
.................... ......+.......................+.......................+
MIDPOINTS
21.000)
20.000)
19.000)
18.000)*
17.000) *
16.000) M M M
].5.000) * * * M*
14.000)
13.000)
12.000)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WI TH *'S, N'S OTHERWISE
MEAN 16.233 15.767
STD.DEV. 1.401 .971
R.E.S.D. 1.603 1.092
S. E. M. .809 .561.
MAXIMUM 17.800 16.600
MINIMUM 15.100 14.700
SAMPLE SIZE 3 3 15.550
1.344
1.684
.950
16.500
14.600
2 15.100
.566
.709
.400
15.500
14.700
2
ALI. GROUPS COMBINED ************RR#*##RR#********* ANALYSIS OF VARIANCE
TABLE *****R*k**R#k*#kk###**RR#**k***
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 15.730 * BETWEEN GROUPS 1.6227 3 .5409 .41 .7526
STD.DEV. 1.031 * WITHIN GROUPS 7.9383 6 1.3231
R.E.S.D. 1.052 * p > 0.05;
S. E. M. .326 * TOTAL 9.5610 9 NOT SIGNIFICANT
*********************************************************************************k**********
MAXIMUM 17.800
MINIMUM 14.600 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 6 1.11 .4159
************#***********R***********#***#**#**********************#******#******#***********
SAMPLE SIZE 10
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 3 .47 .7271
* BROWN-FORSYTHE 3, 4 .43 .7403
74OxGEiC1

88976037
8ZT8'
££68' Z£'
OZ' S
E 3HJ.ASN03-NM0218
H073M x
Y
7VI103 38 OJ. 03Wf1SSV ,LON S3JNVIHtiA
df1O219-NIHJ.IM 2I03 SJI,LSIJ.VJ.S ,LS3J,
3JNVINVA d0 SISx7VNV xVM-3N0 Y
Y
Y
xxxxxxYYY4Yx YxxxYxx xxxxxx YYYx xxYYYYYxYxxxxYxY rYrYrxrY xxYxrrYxxYYxYxYxxYYr rYxYYxrxrYrxrYxrxY x
01 RZIS 37dWVS
460L' 86' 9 'f S30NVI2lVA 7V[ld3 i103 J.S3,L S,ON3A37 r 00£'E6 W(1WINIW
xxxxxxYYrrxY xxxYxxr YYxxrx xxxx YxYYrrxxxxYYxxxx YxxxYYxx YYxxYrYxrxYYxYY4Yxxx YxYxYYYYxYYYYxxrrx Y
. OOE'ZS WfIWIXVW
SNVJI3IN9IS ,LON 6 OTOS'69 9VJOJ x 6LB'
' 'W '3 s
'
'
'
f50'O < d Y BT8
Z S
3
N
O
'
8LET'0T 9 L9Z8'09 SdflO239 NIH,LIM Y 6LL'Z A30
OJS
L6£8' 6Z' 4i68'Z E E6L9'B Sdf10i10 N33MJ.36 Y 0E6'94 NV'3W
xJ.I7IflVfl02Id
7IV,L
3[1] VA
3
321VIlOS NV3W
30
S32IVNOS 30 W[IS
30NIlOS x
Y
Y
rxxrYYxrrxYYYxxxYxxYYxxxYxxxYYY 37tIVJ. 3.7NVIUVA 30
SIS1i7VNV YYrrYxYYrxrYYxYYxxYxxYYrYYxYYrY 03NIf1WOJ Sdf1O21`J 77V
Z
00£'~6 Z
006'66 E
009'66 £ 3'LIS
006'E6 3'IdWVS
wf1wINIW
00S'L6 006'L6 006'66 00£'ZS WOWIXVW
00T'Z 00S'T 8T6'T T£6'Z W'8 'S
ZZL'£ 6S9'Z £9L'Z 696'6 '0'S'3'il
OL6'Z TZT'Z 9S6'Z OIZ'6 A30'aJ.S
006'S6 006'96 00E'L6 EE6'L6 NV3W
3SIMN3HJ.O S.N 'S,Y HJ.IM 30IONIOO A3HJ. 3I S.W AQ 03.LON80 3iJV SNV3W d(10219
(005'06
(000'Z4
x Y(00S'E6
N Y Y (000'S6
N (005'96
r Y w w(000' 84
Y (00S'64
(000'i5
Y(005'ZS
(000'6S
SJ.NIOdOIW
+ .......................+.......................+.......................+.......................
WVHS .LS3,L0T0 ,tS3,L9a 332I
J.JH 30 WVBJOJ.SIH
H2IIiSOM S?IdHM £ 2IdZ3V SdA'IF1A ZI1001,VY2H ,30 SIS2MNf7
£ZHOO d'IgFIs
S00'6ZLT-I
qzoda'd Teuz,3

Final Report
I-1729.005
TABLE CCH24
ANALYSIS OF NEUTROPHIL COUNTS AFTER 3 WEEKS EXPOSURE
HISTOGRAM OF NEUTS
REF D6TEST DIOTEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
45.000)
42.000)*
39.000) M*
36.000)N
33.000) * *
30.000) *
27.000) M* N
24.000) *
21.000) *
18.000)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 34.667 25.667 27.000 38.000
STD.DEV. 5.508 2.517 8.485 .000
R.E.S.D. 6.481 2.729 10.635 .000
S. E. M. 3.180 1.453 6.000 .000
MAXIMUM 41.000 28.000 33.000 38.000
MINIMUM 31.000 23.000 21.000 38.000
SAMPLE SIZE 3 3 2 2
ALL GROUPS
COMBINED ***A**************#*******h****
* * * A * k * * * * * * * * * * * * * * * * * * * * * * * * * *
ANALYSIS OF VARIANCE TABLE
MEAN 31.100 * SOURCE
BETWEEN GROUPS SUM OF SQUARES
255.5667 DF
3 MEAN SQUARE
85.1889 F VALUE
3.52 TAIL PROBABILITY
.0888
STD.DEV. 6.674 * WITHIN GROUPS 145.3333 6 24.2222
R.E.S.D. 3.963 * p > 0.05;
S. E. M. 2.111 * TOTAL 400.9000 9 NOT SIGNIFICANT
**********************k*************A*****k**********.F***1.**#*******k*********1***R****k****
MAXIMUM 41.000
MINIMUM 21.000 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 6 8.67 .0133
***********R*****f***********************A***************#*********R**#*****#********#A*****
SAMPLE SIZE 10
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 4 1.65 .3135
* BROWN-FORSYTHE 3, 2 3.07 .2553
NZ.0.2r.fOa Cf

Final Report
I-1729.005
TABLE CCH25
ANALYSIS OF LYMPHOCYTE COUNTS AFTER 3 WEEKS EXPOSURE
HISTOGRAM OF LYMPHS
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
81.000)
78.000)
75.000) *
72.000) M
69.000) * *
N
66.000) *
63.000)N * M*
60.000)
57.000) *
54.000)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 64.000 72.000
STD.DEV. 6.083 2.000
R.E.S.D. 7.163 2.047
S. E. M. 3.512 1.155
MAXIMUM 68.000 74.000
MINIMUM 57.000 70.000
SAMPLE SIZE 3 3 70.000
8.485
10.635
6.000
76.000
64.000
2 62.000
.000
.000
.000
62.On0
62.000
2
ALL GROUPS COMBINED ******************************* ANALYSIS OF VARIANCE TABLE * * * * * * * * * * *
* * * * * * * * * * * * * * * * k * * *
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 67.200 * BETWEEN GROUPS 169.6000 3 56.5333 2.20 .1886
STD.DEV. 5.996 * WITHIN GROUPS 154.0000 6 25.6667
R.E.S.D. 3.963 * p > 0.05;
S. E. M. 1.896 * TOTAL 323.6000 9 NuT SIGNII'ICAN'P
#************1#****************A***A*k**R*il**************#********A***it****#***#*************
MAXIMUM 76.000
MINIMUM 57.000 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 6 9.29 .0113
*R*R****************k****k**************k***********************************k***************
SAMPLE SIZE 10
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 4 1.16 .4291
* BROWN-FORSYTHE 3, 2 1.97 .3548
E;EO94sed

Final Report
I-1729.005
TABLE CCH26
ANALYSIS OF MONOCYTE COUNTS AFTER 3 WEEKS EXPOSURE
HISTOGRAM OF MONO
REF D6TEST U10TEST SHAM
.......................+.......................+.......................+.......................+
VAR 9
EXCLUDED VALUES NOT REPORTED
VALUES
** * **
TABULATIONS AND COMPUTATIONS WHICH FOLLOW EXCLUDE VALUES LISTED ABOVE
MIDPOINTS
2.100)
1.950) M
1.800)
1.650)
1.500)
1.350)
1.200)
1.050)M** M
.900)
.750)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S N'S OTHERWISE
MEAN 1.000 2.000 1.000 .000
STD.DEV. .000 .000 .000 .000
R.E.S.D. .000 .000 .000 .000
S. E. M. .000 .000 .000 .000
MAXIMUM 1.000 2.000 1.000 .000
MINIMUM 1.000 2.000 1.000 .000
SAMPLE SIZE 3 1 1 0
ALL GROUPS COMBINED ******************************* ANALYSIS OF VARIANCE
TABLE ******#********k#***********R**
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 1.200 * BETWEEN GROUPS .8000 2 .4000 .00 1.0000
STD.DEV. .447 * WITHIN GROUPS .0000 2 .0000
R.E.S.D. .000 *
p > 0.05;
S. E. M. .200 * TOTAL .8000 4 NOT SIGNIFICANT
* 1 * * *
MAXIMUM 2.000 * * # * * * * * * * R * * * * k * * # * * * * A * * * * * * k * * * * * * * * * * * *
f * * * * * * * * * * rt * * f M * * * * * * * * * * * * * * * * i. * k * t * * * * * # *
MINIMUM 1.000 * LEVENE'S TEST FOR EQUAL VARIANCES 2, 2 .00 1.0000
#*A*#************************************************************k**************************
SAMPLE SIZE 5
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 2, 0 .00 .0000
* BROWN-FORSYTHE 2, 0 .00 .0000
OV0946eFi

Final Report
1-1729.005
TABLE CCH27
ANALYSIS OF RETICULOCYTE COUNTS AFTER 3 WEEKS EXPOSURE
HISTOGRAM OF RETCTN
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
1.800)
1.650)
*
1.500) ** M
1.350) *
1.200) N
1.050) M
.900)N *
*
.750)
.600) *
.450)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN .933 1.267
STD.DEV. .416 .404
R.E.S.D. .478 .478
S. E. M. .240 .233
MAXIMUM 1.400 1.500
MINIMUM .600 .800 1.000 1.550
.141 .071
.177 .089
.100 .050
1.100 1.600
.900 1.500
SAMPLE SIZE 3 3 2 2
ALL GROUPS COMBINED ***k*************R************* ANALYSIS OF VARIANCE
TABLE ****R**************************
*
* SOURCE SUM OF SQUARES DF MEAN SQUA RE F VALUE TAIL PROBABILITY
*
MEAN 1.170 * BETWEEN GROUPS .5427 3 .1809 1.55 .2951
STD.DEV. .371 * WITHIN GROUPS .6983 6 .1164
R.E.S.D. .286 * p > 0.05;
S. E. M. .117 * TOTAL 1.2410 9 NOT SIGNIFICANT
********************************************************************************************
MAXIMUM 1.600
MINIMUM .600 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 6 2.94 .1207
SAMPLE SIZE 10
***********1*********************************************************************************
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 3 6.68 .0765
* BROWN-FORSYTHE 3, 5 2.12 .2160
tVaXsea

Final Report
I-172.9.005
TABLE CC1128
CLINICAL CHEMISTRY FOR 6 WEEK SACRIFICE OF MICE
NO. LABEL CIG
TYPE GLUCOSE
mg/dl CHOL
mg/dl TGA
mg/dl CREAT
mg/dl BUN
mg/d1 URIC ACID
mg/dl TOT PROT
g/dl ALBUMIN
g/dl A/G RAT10
---- -------- ---------- ---------- ---------- ---------- ---------- ------- ---------- ----------
----------
1 1151 REF 210.700 86.700 112.800 .460 27.900 3.100 4.800 2.500 1.087
2 1152 REF 168.700 76.900 118.800 .320 27.400 2.700 4.400 2.400 1.200
3 1153 REF 260.300 82.300 114.800 .470 34.300 2.800 4.500 2.400 1.143
4 1163 D6 173.700 88.600 119.500 .340 26.200 2.800 4.700 2.300 .958
5 1164 D6 121.500 87.900 133.800 .380 24.600 2.100 4.600 2.300 1
6 1165 D6 191.200 89.600 124.200 .350 28.300 1.800 4.700 2.400 1.043
7 1175 D10 156.500 75.400 208.900 .710 22.500 2 4.700 2.400 1.043
8 1176 D10 195.800 75.700 132.500 .500 29.500 4 4.500 2.300 1.045
9 1177 D10 180.800 90 88.200 .350 24.700 .300 5.300 2.700 1.038
10 1186 SHAM 187.900 76.800 49.200 .400 19.700 1.200 4.900 2.500 1.042
11 1188 SHAM 215.500 82.600 42.900 .320 18.100 .500 4.600 2.500 1.190
12 1189 SHAM 208.900 87.600 43.200 .340 15.200 .400 4.500 2.400 1.143
C.VV 74Ci00

Final Report
1-1729.005
TABLE CCH29
CLINICAL CHEMISTRY FOR 6 WEEK SACRIFICE OF MICE
NO. LABEL LDH
U/1 ALKPHOS
U/1 SGPT
U/1 SGOT
U/1 CALCIUM
mg/dl PHOS
mg/dl
--------- ---------- ---------- ---------- ----------
1 1151 152 70 51 128 9.600 7.600
2 1152 272 70 NRXa~ NRX 8.100 7.900
3 1153 117 65 40 112 10.300 8.300
4 1163 361 64 NRX NRX 8.500 7.200
5 1164 157 59 51 143 9 7.500
6 1165 215 59 55 195 8.600 8.600
7 1175 229 75 60 179 9.200 7.500
8 1176 401 52 NRX NRX 9.100 7.700
9 1177 103 68 NRX NRX 8.600 8.600
10 1186 195 63 NRX 187 8.800 7.400
11 1188 105 61 NRX 108 7.600 8.200
12 1189 138 56 NRX 68 8.700 8.900
aNRX =NO REACTION ABOVE BACKGROUND
Etro~wsea

Final Report
1-1729.005
TARLE CCH30
HEMATOLAGY NOR 6 WEEK SACRINICE OF MICE
NO. LABEL CIG
TYPE WBC
thousand RF3C
million HG13
yl FICT
$ NEUTS
2 LYMPIIS
% MONOCYTE
% RETCTN
$ PLATELET
----
1 --------
1151 ----------
REE ----------
6.200 ----------
9.960 ----------
16.900 ----------
49.400 ----------
26 ----------
74 -----------
NIt' ----------
4.100 ----------
1
2 1152 REF 7.100 9.110 16.100 46.700 25 74 MP 3.100 1.600
3 1153 REF 7.700 8.270 15.600 41.600 17 82 1 6.800 1.700
4 1163 D6 8.300 9.460 16.700 47.200 21 76 rn< 4.700 1.400
5 1164 D6 6.100 9.470 16.800 46.900 29 68 Nk 5.400 1.500
6 1165 D6 24 9.680 16.300 49 28 71 NR 6.900 Nlt
7 1175 D10 7.500 9.690 17.200 48.100 52 38 N1< 1.100 1.500
8 1176 D10 5.700 9.830 16.800 48.300 24 74 N1< 3.400 1.100
9 1177 D10 14.600 8.160 17.200 41.300 31 68 NR 3.900 1.500
10 1186 SHAM 8.900 9.410 15 47.100 30 69 1 5.100 1.100
11 1188 SIIAM 7.300 9.860 18.100 49.100 41 59 NIZ 3.200 1.200
12 1189 SHAM 21.300 9.200 16.400 46.800 43 55 2 7.600 1.300
aNR = NUNE RI:PORTED OR ODSL'ItVED.
~t~oy~ssa

Final Report
1-1729.005
TABLE CCH31
HEMATOLOGY FOR 6 WEEK SACRIFICE OF MICE
NO. LABEL PMNCTN EOSIN
$
1
1151 -- NRa ----
NR
2 1152 NR 1.0
3 1153 NR NR
4 1163 NR 2.0
5 1164 NR 2.0
6 1165 NR 1.0
7 1175 NR NR
8 1176 NR 1.0
9 1177 NR 1.0
10 1186 NR NR
11 1188 NP, NR
12 1189 NR NR
aNR = NOT REPORTED OR OBSERVED
stroy1,Gsa

Final Report
1-1729.005
TABLE CCH32
ANALYSIS OF GLUCOSE VALUES AFTER 6 WEEKS EXPOSURE
IIISTOGRAM OF GLUCOSE
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOIN'PS
280.000)
260.000)*
240.000)
220.000)M *
200.000) * * M
180.000) * M *
160.000)* N *
140.000)
120.000) *
100.000)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 213.233 162.133
STD.DEV. 45.853 36.261
R.E.S.D. 48.165 41.581
S. E. M. 26.473 20.935
MAXIMUM 260.300 191.200
MINIMUM 168.700 121.500
SAMPLE SIZE 3 3 177.700
19.833
21.695
11.450
195.800
156.500
3 204.100
14.412
16.578
8.321
215.500
187.900
3
ALL GROUPS COMBINED ***************************x*** ANALYSIS OF VARIANCE TABLE
***********x*******************
*
* SOURCE SUM OF SQUARES OF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 189.292 * BETWEEN GROUPS 4993.2949 3 1664.4316 1.66 .2523
STD.DEV. 34.417 * WITHIN GROUPS 8036.7316 8 1.004.5915
R.E.S.D. 27.294 * p > 0.05;
S. E. M. 9.935 * TOTAL 13030.0254 11 NOT SIGNIFICANT
MAXIMUM 260.300
*k*t#************k******************k***********************k**********************k*********
MINIMUM 121.500 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 8 1.22 .3621
SAMPLE SIZE 12
**************x*************************************k**********k**k******k****k************k
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 4 1.59 .3235
* BROWN-FORSYTHE 3, 5 1.66 .2897
9ttQ946Bc4

Final Report
1-1729.005
TABLE CCH33
ANALYSIS OF CHOLESTEROL AFTER 6 WEEKS EXPOSURE
HISTOGRAM OF CHOL
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
92.000)
90.000)
88.000)
86.000)*
84.000)
82.000) M
80.000)
78.000)
76.000) *
74.000)
GROUP MEANS ARE DENOTED BY M'S
F
* *
M* *
M
N
** *
THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 81.967 88.700 80.367 82.333
STD.DEV. 4.908 .854 8.344 5.405
R.E.S.D. 5.185 .921 9.858 5.662
S. E. M. 2.834 .493 4.817 3.121
MAXIMUM 86.700 89.600 90.000 87.600
MINIMUM 76.900 87.900 75.400 76.800
SAMPLE SIZE 3 3 3 3
ALL GROUPS COMBINED **********R*#****R*##****#*#R** *************k*k***************
ANALYSIS OF VARIANCE TABLE
R
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 83.342 * BETWEEN GROUPS 121.4093 3 40.4698 1.31 .3369
STD.DEV. 5.790 * WITHIN GROUPS 247.3202 8 30.9150
R.E.S.D. 4.611 * p > 0.05;
S. E. M. 1.671 * TOTAL 368.7294 11 NOT SIGNIFICANT
MAXIMUM 90.000
**R**#RR*#kR#R#**#*********R**##*#R*#***RR*R*****R****#******************R*#*******#********
MINIMUM 75.400 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 8 2.87 .1039
SAMPLE SIZE 12
******#****RR*#*R********#R**#******R****#*****#****#**********#*****#***A**************#***
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 3 2.89 .2030
* BROWN-FORSYTHE 3, 5 1.31 .3687
Z.Vos11sea

Final Report
I-1729.005
TABLE CCH34
HISTOGRAM OF TGA
ANALYSIS OF TRIGLYCERIDES AFTER 6 WEEKS EXPOSURE
REF U6TL:ST D L OTE ST SIIAM
....................... r....................... i....................... +.......................
+
MIDPOINTS
270.000)
240.000)
210.000)
180.000)
150.000)
120.000)M**
90.000)
60.000)
30.000)
.000)
*
M* *
*
M
k *
`~GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE W1TH *'S, N'S OTHERWISE
MEAN 115.467
STD.DEV. 3.055
R.E.S.D. 3.411
S. E. M. 1.764
MAXIMUM 118.800
MINIMUM 112.800
SAMPLE SIZE 3
ALI. GROUPS COMBINED
MEAN 107.400
STD.DEV. 47.010
R.E.S.D. 17.694
S. E. M. 13.571
MAXIMUM 208.900
MINIMUM 42.900
SAMPLE SIZE 12
125.833a 143.200a
7.289 61.057
8.152 67.233
4.208 35.251
133.800 208.900
119.500 88.200
3 3
*********k*******#*k*******AA** ANALYSIS
*
*
SOURCE SUM OF SQUARES
* BETWEEN GROUPS
* WITNIN GROUPS
*
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS L'OR WITHIN-GROUP
* VARIANCES NOT ASSUMEI) TO BE EQUAI.
* WELCII
* BROWN-FORSYTHE
45.100
3.554
4.196
2.052
49.200
42.900
3
OF VARIANCE TABLE
R * * !F * * * * * * * * * * * * * * k * * * * * * * * * * * k
UE MEAN SQUARE L' VALUE TAIL PROI3ABILI'1'Y
16703.3672 3 5567.7891 5.86 .0204
7606.1527 8 950.7691
* TOTAI. 24309.5195 ll N<_ 0.05
* * * * * * * * * * * * * * * * # k * * A * A * * * * * * A * * * * * * * * * k * * * * * * * * * *
* * * * k * * * * * k * * A * * k * * * * * * * A * * * * * * * * * * * * * * * * *
* LEVENE'S TEST FOR EQUAL VARIANCES 3, 8 5.68 .0221
* * * * * * * * * * * * * * * * * * * * * * * # * * * * * * * * * * * * * * * * * * * * * * * * A *
* * # * * * * l. * * A A A * * * 4 * * * * * A A * A * * * * * * * * A * * * * * * !.
3, 4 191.82 .0001
3, 2 5.86 .1493
aS1GNl1'ICANTI.Y DIFFI~;ItI'N'P FROM SIIAM CON'PROL, 5'I'IIDI:N'I'IGI?Il P F ` 0.05.
8W94,GeR

Final Report
1-1729.005
TABLE CCH35
ANALYSIS OF CREATININE AFTER 6 WEEKS EXPOSURE
IIISTOGRAM OF CREAT
MIDPOINTS
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
.750)
.700)
.650)
.600)
*
.550)
.500)
.450) **
M
.400) N R
.350) M*
.300) * *
M
*
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S , N'S OTHERWISE
MEAN .417 .357
STD.DEV. .084 .021
R.E.S.D. .099 .024
S. E. M. .048 .012
MAXIMUM .470 .380
MINIMUM .320 .340 .520 .353
.181 .042
.194 .048
.104 .024
.710 .400
.350 .320
SAMPLE SIZE 3 3 3 3
ALL GROUPS COMBINED ******************************* ANALYSIS OF VARIANCE
TABLE *********************R*********
*
* SOURCE
SUM OF SQUARES DF MEAN SQUA
RE F VALUE TAIL PROBABILITY
*
MEAN .412 * BETWEEN GROUPS .0546 3 .0182 1.74 .2367
STD.DEV. .112 * WITHIN GROUPS .0838 8 .0105
H.E.S.D. .078 * p > 0. 05;
S. E. M. .032 * TOTAL .1384 11 NOT SIGNIFICANT
MAXIMUM .710
****R*****R****#*********************************************************k**k***************
MINIMUM .320 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 8 2.97 .0969
SAMPLE SIZE 12
#R*R**A*************####*k****R************R***R****#******************kk*t1*************A***
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 4 .96 .4940
* BROWN-FORSYTHE 3, 3 1.74 .3308
E,V0946eg

TABLE CCH36
ANALYSIS OF BLOOD UREA NITROGEN AFTER 6 WEEKS EXPOSURE
IIISTOGRAM OL' BUN
Final Report
1-1729.005
RF.L' D6TE:S'P 1)1UTEST SIIAM
.......................+........................ 1....................... +........................
h1IDPOINTS
36.000)
34.000) *
32.000)N * M*
30.000)** M
28.000) *
26.000)
24.000)
22.000) M
20.000) *
1.8.000)
`'CROUI' MEANS ARE DENO'l'EU BY M'S Il THEY COINCIDE WITH *'S, N'S OTHE.IfWI SE
MEAN 31.750d 30.533 a 31.550' 21.350
S'l'f).DE:V. 1.953 2.238 .283 1.202
R.E.S.I). 2.302 2.422 .354 1.507
S. L'. M. 1.127 1.292 .200 .850
MAXIMUM 34.000 32.900 31.750 22.200
MINIMUM 30.500 28.450 31.350 20.500
SAMPLE S1lE: 3 3 2 2
ALI. GROUPS COM6INEl) i. * * * * * * * * * A k * * * * * * * * * A * k * k * * * * *
ANALYSIS A * * * * *
OF VARIANCI: 'I'AIiL,E * * A A * * * A * * A A k * * * * A * * * * * k *
*
* SOURCE SUM OF SQUARES DE' MEAN Ei(_)L1ARE E' VALUE '1'AIL. PROBAI3II,ITY
*
MEAN 29.265 * BETWEEN CROIIPS 159.0886 3 53.0295 16.60 .0026
S'1'D.DEV. 4.450 * WITHIN GROUPS 19.1717 6 3.1953
R.E.S.D. 1.497 *
S. E. M. 1.407 * TO'l'AL 178.2602 9 1) 0.05
MAXIMUM 34.000 * * * k * * * * k * A * * * A * A * A * * A k A * * A A * * * A A * k * A * * A A * *
* * A A * * * R A * A A * k A A * A k * A * * A * * * k k * A k * A * A A A * * k A * A k A A * k
MINIMUM 20.500 * LEVhiNE'S TES'1' FOR EQUAL VARIANCES 3, 6 1.69 .2672
SAMPI.E; S f'LL; 10 * * k * * A * * * * A * A * A A * * A k A A * k k * * * k * * * A * * * * k * *
* * k A A A * A * * * * * * A k * A R A A A A * * A A * * * * * * * A * * * A A A * k A * * * * * *
A *
* ONE-WAY ANALYSIS UL' VARIANCE
* TEST STATISTICS FOR WITHIN-GROl1P
* VARIANCES NO'l' ASSLIMEU TO 13E EQUAL
* WELCH 3, 3 30.51 .0095
* IIROWN-FORSYTHE 3, 5 21.51 .0028
`)5IGN11'LCANTLY DIl'l'ERICNT FROM :.i11AM CON'1'ROL, S'l'lJI)KN'I'1'I.I;D RAN(;I: '1'I;ST, I' <
0.05.
OS09G66R

Final Report
1-1729.005
TABLE CCH37
HISTOGRAM OF ORICACID
ANALYSIS OF URIC-ACID AFTER 6 WEEKS EXPOSURE
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
7.000)
6.000)
5.000)
4.000)
3.000)M** *
*
2.000) M* M
1.000)
.000)
-1.000)
-2.000)
*
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 2.867
STD.DEV. .208
R.E.S.D. .239
S. E. M. .120
MAXIMUM 3.100
MINIMUM 2.700
SAMPLE SIZE 3
ALL GROUPS COMBINED
MEAN 1.975
STD.DEV. 1.182
R.E.S.D. .698
S. E. M. .341
MAXIMUM 4.000
MINIMUM .300
SAMPLE SIZE 12
2.233 2.100
.513 1.852
.580 1.944
.296 1.069
2.800 4.000
1.800 .300
3 3
*****************#*************
*
M
**
.700
.436
.512
.252
1.200
.400
3
ANALYSIS OF VARIANCE TABLE
* * * * * * * * * * * * * * * * * * * k * * * * * * * * * * *
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
* BETWEEN GROUPS 7.5092 3 2.5031 2.55 .1289
* WITHIN GROUPS 7.8533 8 .9817
* p > 0. 05;
* TOTAL 15.3625 11 NOT SIGNIFICANT
f*************************************#****R*********A********************************k*****
* LEVENE'S TEST FOR EQUAL VARIANCES 3, 8 2.70 .1161
*A*A****************************************************************************kk**********
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 4 15.18 .0119
* BROWN-FORSYTHE 3, 3 2.55 .2312
IS0946et?

Final Report
1-1729.005
TABLE CCH38
ANALYSIS OF TOTAL PROTEIN AFTER 6 WEEKS EXPOSURE
HISTOGRAM OF TOTPROT
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
5.550)
5.400)
5.250) *
5.100)
4.950)
4.800)* N
4.650) M** * M
4.500)M * *
4.350)*
4.200)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 4.567 4.667
STD.DEV. .208 .058
R.E.S.D. .239 .068
S. E. M. .120 .033
MAXIMUM 4.800 4.700
MINIMUM 4.400 4.600
SAMPLE SIZE 3 3 4.833
.416
.478
.240
5.300
4.500
3 4.667
.208
.239
.120
4.900
4.500
3
ALL GROUPS COMBINED ******************************* ANALYSIS OF VARIANCE TABLE * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * *
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL. PROBABILITY
*
MEAN 4.683 * BETWEEN GROUPS .1100 3 .0367 .56 .6580
STD.DEV. .241 * WITHIN GROUPS .5267 8 .0658 P > 0
05;
R.E.S.D. .218
S. E. M. .069 *
TOTAL
.6367
11 .
NOT SIGNII'ICANT
MAXIMUM 5.300
********************************************************************************************
MINIMUM 4.400 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 8 3.39 .0745
SAMPLE SIZE 12
***************************i#********************************************************k**k****
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 4 .28 .8363
* BROWN-FORSYTHE 3, 4 .56 .6708
9V,71.160IR

Final Report
1-1729.005
TABLE CCH39
ANALYSIS OF ALBUMIN AFTER 6 WEEKS EXPOSURE
HISTOGRAM OF ALBUMIN
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
2.750)
2.700) *
2.650)
2.600)
2.550)
2.500) * **
2.450)N N N
2.400)** * * *
2.350) N
2.300) ** *
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 2.433 2.333
STD.DEV. .058 .058
R.E.S.D. .068 .068
S. E. M. .033 .033
MAXIMUM 2.500 2.400
MINIMUM 2.400 2.300 2.467
.208
.239
.120
2.700
2.300 2.467
.058
.068
.033
2.500
2.400
SAMPLE SIZE 3 3 3 3
***********************t***k***
ALL GROUPS COMBINED *******************************
ANALVSIS OF VARIANCE TABLE
*
* SOURCE SUM OF S QUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 2.425 * BETWEEN GROUPS .0 358 3 .0119 .90 .4842
STD.DEV. .114 * WITHIN GROUPS .1 067 8 .0133
R.E.S.D. .095 . P > 0.05;
S. E. M. .033 * TOTAL .1 425 11 NOT SIGNIFICANT
****************************************************************************************1***
MAXIMUM 2.700
MINIMUM 2.300 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 8 4.55 .0386
***************************************************M***************k************************
SAMPLE SIZE 12
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 4 2.26 .2236
* BROWN-FORSYTHE 3, 3 .90 .5350
Esoy4sea

c,p 0, d' LS'IJ39NV21 (1;17..IJA;IUn,LS ';I,L,1.;1?lVD1 );JJNaiI;Ir1.121 WO?1.a
J,[1;]217:L1IU l.'I,LNVJI;lINOIS~ 889'76054
;0' 0> (I ' LS;1L a`)NVN (I:II I J,N;I(InJ s''IO2I;LNOJ WVIIS IJO?1:I 1N;121;Ir1;T I U vI,LNV;)I
ITN.)IS
e
0950' BO' S S '£ BII,LxS?IOrI-NMONB v
SOST' T8£ £ 'C H073M
'IvnOa 39 01 (I.1WnSSV ,LON S;IONVIiIVA
d00NJ-NIN,LIM 210a SOIJ,SUVJ.S J.S:1,L
90NtlI2ltlA ,10 SISx'IVNV xVM-NN0 x
x
v
v
xxxxvxxvrxvx
66LT' xxxx.xx xxxxxxxxxx
60'Z xxrr.rx xrxxxxx
8 xxxx.xrxxx
'E xxvx.xxrrx~txxxrxxxxx
S;lONVI2IVA 7VI1(7;1 210.1 xxxxxxxxxxxxxxxsxx
J,S3J. S,3N;lA:i'I x
v ZT
8S6' :1ZIS 87dWVS
WnWINIW
xrxxxrrxxvxx xxxxxxr xxxxxxrxxx xrxrxxr vxrrxxx xxxxxxxxxx xxxxrxxxxxxvxrxvxxvx rxxraxxxxxxxxxxxxx x
00z'I wnwlxvw
soo - ~T II RZ90 'IVJ.oJ, x ZZO w
v T60' 'U'S'3'N
LZ00' 8 9TZ0' Sdn021J NIN.LIM v 9L0' A7U'U.LS
£6Z0' 80'S L£T0' £ Zi60' SdnO?IJ N;17MJlfl v RLOT NV7W
AJ,I'IIL1V90Nd
'ITV,L
an'TVA ;T
:ailvntSS
NVlIW
dCl
s:mvnbs .ao WNS
(lON(1oS v
x
x Y x x x'F t Y x Y x Y x r x Y x Y x x r x x r x V M r Y Y r
4
:1'1fIV,L ,'1JNVINVA 70 SISA'IVNd vxvxxxxvxrrvvxxxvvvv.rr.rxrx.vv
aaNlnwoD SdnWID 'Yiv
£ I £ I ;17.I S R'IdWVS
Z60T 8E0'T 856 L80T WOWINIW
06T'I SVOT E60'I 00Z'I WnwlXtlw
660' Z00' SZO' EEO' 'W
S80' 600' 660' 8S0' U'S'3'i1
9L0
SZT'T 600'
Z60'T £60'
~P T00'T LSO'
E6T'T A3C1'CIJ.S
NV;1W
;1SIMN81LL0 S,N 'S, x IIJ.IM 'IOTJNIOJ ISII,L 1.11 S,W xI] C1:7,LON',lCl 'J21V SNVSW dn0?IJ-,
(088
(0Z6'
v (096'
W (000'i
x
N
x
v vxW v (060'I
v(0R0'T
(0ZII
W(09I'T
v(OOZ'T
(06ZT
SJ,NIOdUIW
+ .......................+.......................+.......................+. ....................
WVnS ,LS;l1LO [(I J,S7J19CI 1;T21
OTJ,VN7V :10 WV?I70.LSIII
H2if1SOdX3 S?XHHM 9'tIS,L3K OIZFRi D/V 30 SIS7i'IFZNfI
S00' 6ZLT-I OPHOO H'IffFts
q.zoda-d TUuz3

TABLE CCH41
HISTOGRAM OF LDH
ANALYSIS OF LACTIC DEHYDROGENASE AFTER 6 WEEKS EXPOSURE
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
440.000)
400.000)
360.000)
320.000)
280.000)*
*
*
240.000) N M
200.000)N * *
160.000)* * N
120.000)* * **
80.000)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 180.333
STD.DEV. 81.292
R.E.S.D. 93.805
S. E. M. 46.934
MAXIMUM 272.000
MINIMUM 117.000
SAMPLE SIZE 3
ALL GROUPS COMBINED
MEAN 203.750
STD.DEV. 98.048
R.E.S.D. 90.324
S. E. M. 28.304
MAXIMUM 401.000
MINIMUM 103.000
SAMPLE SIZE 12
244.333 244.333
105.116 149.591
119.388 160.321
60.689 86.366
361.000 401.000
157.000 103.000
3 3
*********A********1fi*R********I**
*
146.000
45.530
50.143
26.287
195.000
105.000
3
ANALYSIS OF VARIANCE TABLE
Final Report
I-1729.005
* * * * * * * * k * k * * * * * * * * * k * * * * * * * k * *
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
* BETWEEN GROUPS 21532.2500 3 7177.4170 .68 .5876
* WITHIN GROUPS 84216.0000 8 10527.0000
* p > 0.05;
* TOTAL 105748.2500 11 NOT SIGNIFICANT
* * * * * * * * * * * * * * * * * * * * * * * * * * * * k * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * k * * ~r * * * * * * * * * * * * * * * * *
* LEVENE'S TEST FOR EQUAL VARIANCES 3, 8 1.15 .3874
*L************************************k***k****k******************k*****************k*******
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 4
* BROWN-FORSYTHE 3, 5
.78 .5616
.68 .6002
SS09L68d

Final Report
1-1729.005
TABLE CCH42
HISTOGRAM OF ALKPHOS
ANALYSIS OF ALKALINE PHOSPHATASE AFTER 6 WEEKS EXPOSURE
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
78.000)
75.000)
72.000)
69.000)M*
*
*
66.000)* N
63.000)
60.000)
57.000)
54.000)
51.000)
*
M*
*
M
*
*
GROUP MEANS ARE DENOTED ElY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 68.333
STD.DEV. 2.887
R.E.S.D. 3.411
S. E. M. 1.667
MAXIMUM 70.000
MINIMUM 65.000
SAMPLE SIZE 3
ALL GROUPS COMBINED
MEAN 63.500
STD.DEV. 6.571
R.E.S.D. 5.163
S. E. M. 1.897
MAXIMUM 75.000
MINIMUM 52.000
SAMPLE SIZE 12
60.667 65.000 60.000
2.887 11.790 3.606
3.411 13.303 4.093
1.667 6.807 2.082
64.000 75.000 63.000
59.000 52.000 56.000
3 3 3
***********R*R*******RR*****R** ANALYSIS OF VARIANCE TABLE *******************************
R
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
* BETWEEN GROUPS 137.6667 3 45.8889 1.09 .4080
* WITHIN GROUPS 337.3333 8 42.1667
* p > 0.05;
* TOTAL 474.9999 11 NOT SIGNIFICANT
***********R*****R**************************************************************************
* LEVENE'S TEST FOR EQUAL VARIANCES 3, 8 3.91 .0545
************************************************x*******************************************
* ONE-WAY ANALYSIS OF' VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 4
* BROWN-FORSYTHE 3, 3
3.60 .1237
1.09 .4731
9SQ!jt,68tj

Final Report
I-172A.005
TABLE CCH43
ANALYSIS OF SGPT AFTER 6 WEEKS EXPOSURE
HISTOGRAM OF SGPT
REF D6TEST D10TEST SIIAM
....................... 1........................................................................
.......+
VAR 14
EXCLUDED
VALUES
QUANTITY NOT SUFFICIENT FOR ANALYSIS
* * * * * * *
TABULATIONS AND COMPUTATIONS WHICH FOLLOW EXCLUDE VALUES LISTED ABOVE
MIDPOINTS
63.000)
60.000)
57.000)
54.000) M
51.000)*
48.000)
45.000)N
42.000)
39.000)*
36.000)
M
*
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 45.500 53.000
STD.DEV. 7.778 2.828
R.E.S.D. 9.748 3.545
S. E. M. 5.500 2.000
MAXIMUM 51.000 55.000
MINIMUM 40.000 51.000
SAMPLE SIZE 2 2 60.000
.000
.000
.000
60.000
60.000
1 .000
.000
.000
.000
.000
.000
0
ALL GROUPS COMBINED **#A***A***AAA**A#*******A***** ANALYSIS OF VARIANCE TABLE
*******************************
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 51.400 * BETWEEN GROUPS 148.7000 2 74.3500 2.17 .3154
STD.DEV. 7.369 * WITHIN GROUPS 68.5000 2 34.2500
R.E.S.D. 4.204 * p > 0.05;
S. E. M. 3.295 * TOTAL 217.2000 4 NOT SIGNIFICANT
MAXIMUM 60.000
AkA*#**AA******#A#AAA**AA#iA#AA##k**#*****kAA**A*#A************AA**#A******************#****
MINIMUM 40.000 * LEVENE'S TEST FOR EQUAL VARIANCES 2, 2 .00 1.0000
SAMPLE SIZE 5
**A**#**A**********#**#A***AA**#*#*******iF***#***k**********#****#***********#****A****ik****
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 2, 3 .39 .7060
* BROWN-FORSYTHE 2, 1 3.62 .3485
4SQ946BR

Final Report
1-1729.005
TABLE CCH44
ANALYSIS OF SGOT AFTER 6 WEEKS EXPOSURE
HISTOGRAM OF SGOT
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
VAR 15
EXCLUDED
VALUES
MIDPOINTS
QUANTITY NOT SUFFICIENT FOR ANALYSIS
* * **
TABULATIONS AND COMPUTATIONS WHICH FOLLOW EXCLUDE VALUES LISTED
ABOVE
220.000)
200.000) *
180.000) M *
160.000) N
140.000) *
120.000)M* N
100.000) *
80.000)
60.000) *
40.000)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 120.000 169.000 179.000 121.000
STD.DEV. 11.314 36.770 .000 60.556
R.E.S.D. 14.180 46.084 .000 67.540
S. E. M. 8.000 26.000 .000 34.962
MAXIMUM 128.000 195.000 179.000 187.000
MINIMUM 112.000 143.000 179.000 68.000
SAMPLE SIZE 2 2 1 3
ALL GROUPS COMBINED ******************************* ANALYSIS OF VARIANCE TABLE
*******************************
R
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 140.000 * BETWEEN GROUPS 5086.0000 3 1695.3333 .77 .5681
STD.DEV. 44.561 * WITHIN GROUPS 8814.0000 4 2203.5000
R.E.S.D. 33.496 * p > 0.05;
S. E. M. 15.755 * TOTAL 13900.0000 7 NOT SIGNIFICANT
MAXIMUM 195.000
****************R***************R**k****************it***************************************
MINIMUM 68.000 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 4 2.00 .2565
SAMPLE SIZE 8
**********************************************************~k#********************k**#*#******
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 4 .80 .5538
* BROWN-FORSYTHE 3, 3 1.50 .3745
asoyW;et4

Final Report
1-1729.005
TABLE CCH4S
ANALYSIS OF CALCIUM AFTER 6 WEEKS EXPOSURE
HISTOGRAM OF CALCIUM
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
10.800)
10.400)*
10.000)
9.600) *
9.200) N **
8.800) M N **
8.400) ** * N
8.000) *
7.600) *
7.200)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 9.333 8.700
STD.DEV. 1.124 .265
R.E.S.D. 1.262 .307
S. E. M. .649 .153
MAXIMUM 10.300 9.000
MINIMUM 8.100 8.500
SAMPLE SIZE 3 3 8.967
.321
.375
.186
9.200
8.600
3 8.367
.666
.785
.384
8.800
7.600
3
ALL GROUPS COMBINED ******************************* ***************/.***************
ANALYSIS OF VARIANCE TABLE
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 8.842 * BETWEEN GROUPS 1.5092 3 .5031 1.07 .4145
STD.DEV. .692 * WITHIN GROUPS 3.7600 8 .4700
R. E:.S.D. .582 * p > 0.05;
S. E. M. .200 * TOTAL 5.2692 11 NOT SIGNIFICANT
MAXIMUM 10.300
#***k**************************************************************************k************
MINIMUM 7.600 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 8 3.04 .0924
SAMPLE SIZE 12
******************#*************************************************************************
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 4 .80 .5558
* BROWN-FORSYTHE 3, 4 1.07 .4556
GS094668

Final Report
1-1729.005
TABLE CCI146
ANALYSIS OF PHOSPHORUS AFTER 6 WEEKS EXPOSURE
fIISTOGRAM OF PHOS
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
9.300)
9.000)
8.700) *
8.400) *
8.100) M
7.800)M N M
7.500) * * * *
7.200) *
6.900)
6.600)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 7.933 7.767
STD.DEV. .351 .737
R.E.S.D. .375 .853
S. E. M. .203 .426
MAXIMUM 8.300 8.600
MINIMUM 7.600 7.200
SAMPLE SIZE 3 3 7.933
.586
.682
.338
8.600
7.500
3 8.167
.751
.785
.433
8.900
7.400
3
ALL GROUPS COMBINED ******************************* *************#****k************
ANALYSIS OF VARIANCE 'fABLE
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE 'PAIL PROBABILITY
*
MEAN 7.950 * BETWEEN GROUPS .2433 3 .0811 .21 .8893
STD.DEV. .555 * WITHIN GROUPS 3.1467 8 .3933
R.E.S.D. .575 * p > 0.05;
S. E. M. .160 * TOTAL 3.3900 11 NOT SIGNIFICANT
MAXIMUM 8.900
#********#*R**************##*##********k#****#****#*#*##*#*****###********#**********k******
MINIMUM 7.200 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 8 .68 .5877
SAMPLE SIZE 12
*******#*#*****#******##**#***#*****#**#***#*****#***#*****#*#**************#**k******k*****
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 4 .11 .9488
* BROWN-FORSYTHE 3, 7 .21 .8889
0Jl1 9f.4O H k3

Final Report
1-1729.005
TABLE CCH47
ANALYSIS OF WHITE BLOOD CELL COUNTS AFTER 6 WEEKS EXPOSURE
HISTOGRAM OF WBC
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
27.000)
24.000) *
21.000) *
18.000)
15.000) *
12.000) N N
9.000)* * N *
6.000)M* * ** *
3.000)
.000)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 7.000 12.800
STD.DEV. .755 9.762
R.E.S.D. .819 11.461
S. E. M. .436 5.636
MAXIMUM 7.700 24.000
MINIMUM 6.200 6.100
SAMPLE SIZE 3 3 9.267
4.706
5.458
2.717
14.600
5.700
3 12.500
7.663
9.005
4.424
21.300
7.300
3
**#*#***#*k#******#*******#**#*
ALL GROUPS COMBINED
ANALYSIS OF VARIANCE TABLE *******************************
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 10.392 * BETWEEN GROUPS 69.0425 3 23.0142 .52 .6797
STD.DEV. 6.197 * WITHIN GROUPS 353.4467 8 44.1808
R.E.S.D. 5.702 * p > 0.05;
S. E. M. 1.789 * TOTAL 422.4891 11 NOT SIGNIFICANT
****#*********************'***********#****#*****#***#*************#*#***#******##********##*
MAXIMUM 24.000
MINIMUM 5.700 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 8 4.93 .0317
***********************##***#*********#*R#**#****i****************#**#***###*#*A#*##***#****
SAMPLE SIZE 12
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 3 .77 .5842
* BROWN-FORSYTHE 3, 5 .52 .6863
1JII.J(tGp O

Final Report
1-1729.005
TABLE CCH48
ANALYSIS OF RED BLOOD CELL COUNTS AFTER 6 WEEKS EXPOSURE
HISTOGRAM OF RBC
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
10.500)
10.200)
k *
9.900) *
9.600) M** * N
9.300)
N **
9.000)M
8.700)
8.400)*
8.100)
7.800)
*
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N' S OTHERWISE
MEAN 9.113 9.537
STD.DEV. .845 .124
R.E.S.D. .866 .147
S. E. M. .488 .072
MAXIMUM 9.960 9.680
MINIMUM 8.270 9.460
SAMPLE SIZE 3 3 9.227
.926
1.092
.535
9.830
8.160
3 9.490
.337
.379
.195
9.860
9.200
3
* * * * * * * * * * * * *
ALL GROUPS COMBINED * * * * * * * * * * * * * * * * * *
ANALYSIS OF VARIANCE TABLE ***k******************k********
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 9.342 * BETWEEN GROUPS .3762 3 .1254 .29 .8283
STD.DEV. .586 * WITHIN GROUPS 3.4028 8 .4253
R.E.S.D. .529 * p > 0.05;
S. E. M. .169 * TOTAL 3.7790 11 NOT SIGNIFICANT
********************************************************************************************
MAXIMUM 9.960
MINIMUM 8.160 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 8 2.67 .1189
k*******************************************************************************************
SAMPLE SIZE 12
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 4 .26 .8500
* BROWN-FORSYTHE 3, 5 .29 .8282
(.7V 0QCt
.7L4

Final Report
1-1729.005
TABLE CCH49
ANALYSIS OF HEMOGLOBIN AFTER 6 WEEKS EXPOSURE
HISTOGRAM OF HGB
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
21.000)
20.000)
19.000)
18.000)
17.000)* M* M**
16.000)M* * M
15.000) *
14.000)
13.000)
12.000)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *' S, N'S OTHERWISE
MEAN 16.200 16.600
STD.DEV. .656 .265
R.E.S.D. .716 .307
S. E. M. .379 .153
MAXIMUM 16.900 16.800
MINIMUM 15.600 16.300
SAMPLE SIZE 3 3 17.067
.231
.273
.133
17.200
16.800
3 16.500
1.552
1.637
.896
18.100
15.000
3
ALE. GROUPS COMBINED ******************************* ANALYSIS OF VARIANCE
TABLE *******kk**********************
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 16.592 * BETWEEN GROUPS 1.1625 3 .3875 .52 .6784
STD.DEV. .803 * WITHIN GROUPS 5.9267 8 .7408
R.E.S.D. .625 * p > 0.05;
S. E. M. .232 * TOTAL 7.0892 11 NOT SIGNIFICANT
********************************************************************************************
MAXIMUM 18.100
MINIMUM 15.000 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 8 2.50 .1335
*************************************************************************i.******************
SAMPLE SIZE 12
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 4 2.09 .2444
* BROWN-FORSYTHE 3, 3 .52 .6960
E9U9&63R

Final Report
I-1729.005
TABLE CCH50
ANALYSIS OF HEMATOCRIT VALUES AFTER 6 WEEKS EXPOSURE
HISTOGRAM OF HCT
REF ' D6TEST DIUTEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
50.000)
49.000) * * *
48.000) N ** N
47.000) * ** **
46.000)N N
45.000)
44.000)
43.000)
42.000) *
41.000) R
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 45.900 47.700 45.900 47.667
STD.DEV. 3.961 1.136 3.985 1.250
R.E.S.D. 4.400 1.330 4.707 1.467
S. E. M. 2.287 .656 2.301 .722
MAXIMUM 49.400 49.000 48.300 49.100
MINIMUM 41.600 46.900 41.300 46.800
SAMPLE SIZE 3 3 3 3
ALL GROUPS COMBINED ****R*****R*#***###**#***#**R** *******************************
ANALYSIS OF VARIANCE TABLE
M
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 46.792 * BETWEEN GROUPS 9.5425 3 3.1808 .37 .7772
STD.DEV. 2.670 * WITHIN GROUPS 68.8467 8 8.6058
R.E.S.D. 2.538 * P > 0.05;
S. E. M. .771 * TOTAL 78.3891 11 NOT SIGNIFICANT
MAXIMUM 49.400
*****************************************R*****k******k*****************k*******************
MINIMUM 41.300 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 8 3.09 .0895
SAMPLE SIZE 12
**********RR**R#R**R#R*#**R****#*k************##*****#********k**#*k*k#*A*f*#kkk*##*k**k*k**
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 4 .28 .8380
* BROWN-FORSYTHE 3, 5 .37 .7789
V9Q946gR

Final Report
1-1729.005
TABLE CCHS1
ANALYSIS OF NEUTROPHIL COUNTS AFTER 6 WEEKS EXPOSURE
HISTOGRAM OF NEUTS
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
55.000)
50.000) *
45.000) *
40.000) M
35.000) N
30.000) ** * *
25.000)M* N *
20.000) #
15.000) *
10.000)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 22.667 26.000 35.667 38.000
STD.DEV. 4.933 4.359 14.572 7.000
R.E.S.D. 5.799 5.117 16.714 8.187
S. E. M. 2.848 2.517 8.413 4.041
MAXIMUM 26.000 29.000 52.000 43.000
MINIMUM 17.000 21.000 24.000 30.000
SAMPLE SIZE 3 3 3 3
ALL GROUPS COMBINED ******************************* ANALYSIS OF VARIANCE TABLE
*******************************
#
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 30.583 * BETWEEN GROUPS 493.5834 3 164.5278 2.16 .1707
STD.DEV. 10.013 * WITHIN GROUPS 609
3333 8 76
1667
R.E.S.D. 7.636 * . . p > 0.05;
S. E. M. 2.891 * TOTAL 1102.9165 11 NOT SIGNIFICANT
MAXIMUM 52.000
##**#****#*#*1t#******fl*******!e**i!***1.*******#******ir*#*********#*#*k#*A#*!.!*****************
MINIMUM 17.000 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 8 3.15 .0864
SAMPLE
SI # *
ZE 12 * * t~ * fi # * # * # # # # * # * i1 * * * * fe # * # # * * * # * f' * # iF # h fr 1' * * .Y #
* * * * # i. # /e * # * # # # 1r * * * * * * * * f. * * * tF * * * * # # k * * * * * * * * * * * *
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 4 2.77 .1750
* BROWN-FORSYTHE 3, 4 2.16 .2354
ssos4sea

Final Report
1-1729.005
TABLE CCH52
HISTOGRAM OF LYMPHS
ANALYSIS OF LYMPHOCYTE COUNTS AFTER 6 WEEKS EXPOSURE
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
MIDPOINTS
91.000)
84.000) *
77.000)M*
70.000)
63.000)
56.000)
49.000)
42.000)
35.000)
28.000)
*
M*
*
*
N
*
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 76.667
STD.DEV. 4.619
R.E.S.D. 5.458
S. E. M. 2.667
MAXIMUM 82.000
MINIMUM 74.000
SAMPLE SIZE 3
ALL GROUPS COMBINED
MEAN 67.333
STD.DEV. 11.765
R.E.S.D. 8.654
S. E. M. 3.396
MAXIMUM 82.000
MINIMUM 38.000
SAMPLE SIZE 12
71.667 60.000
4.041 19.287
4.434 22.513
2.333 11.136
76.000 74.000
68.000 38.000
3 3
*******************************
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH
* BROWN-FORSYTHE
61.000
7.211
8.187
4.163
69.000
55.000
3
ANALYSIS OF VARIANCE TABLE
*******************************
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
* BETWEEN GROUPS 599.3334 3 199.7778 1.73 .2377
* WITHIN GROUPS 923.3333 8 115.4167
* p > 0.05;
* TOTAL 1522.6665 11 NOT SIGNIFICANT
*****#**#******#**#*****##**##*****##*****##*****#**#**#******##*k#****k***#****A*****#*k***
* LEVENE'S TEST FOR EQUAL VARIANCES 3, 8 5.53 .0237
*#*****k*##******#******k#**k****#***#*****##***********************k**#******#*************
3, 4 2.83 .1704
3, 3 1.73 .3317
99Oy4fgd

Final. Report
I-17?9.005
TABLE CCH53
ANALYSIS OF MONOCYTE COUNTS AFTER 6 WEEKS EXPOSURE
HISTOGRAM OF MONO
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
VAR 9
EXCLUDED
VALUES
VALUES NOT REPORTED
** *** *** *
MIDPOINTS
2.100) TABULATIONS AND COMPUTATIONS WHICH FOLLOW EXCLUDE VALUES LISTED ABOVE
1.950) *
1.800)
1.650)
1.500) N
1.350)
1.200)
1.050) M *
.900)
.750)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
MEAN 1.000 .000
STD.DEV. .000 .000
R.E.S.D. .000 .000
S. E. M. .000 .000
MAXIMUM 1.000 .000
MINIMUM 1.000 .000
SAMPLE SIZE 1 0 .000
.000
.000
.000
.000
.000
0 1.500
.707
.886
.500
2.000
1.000
2
*****k*************************
ALL GROUPS COMBINED ANALYSIS OF VARIANCE TABLE *******k***********************
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 1.333 * BETWEEN GROUPS .1667 1 .1667 .33 .6667
STD.DEV. .577 * WITHIN GROUPS .5000 1 .5000
R.E.S.D. .512 * p > 0.05;
S. E. M. .333 * TOTAL .6667 2 NOT SIGNIFICANT
****!************************************i******k*******************************************
MAXIMUM 2.000
MINIMUM 1.000 * LEVENE'S TEST FOR EQUAL VARIANCES 1, 1 .00 1.0000
*********************************************k************************k***********k*********
SAMPLE SIZE 3
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 1, 0 .00 .0000
* BROWN-FORSYTIIE 1, 1 1.00 .5000
1_.9U !)4E',Bg

TABLE CCH54
ANALYSIS OF RETICULOCYTE COUNTS AFTER 6 WEEKS EXPOSURE
HISTOGRAM OF RETCTN
MIDPOINTS
REF D6TEST D10TEST SHAM
.......................+.......................+.......................+.......................+
9.000)
8.000) *
7.000)* *
6.000) N
5 .000) N ** M
4.000)* *
3.000)* M *
2.000)
1.000) *
.000)
GROUP MEANS ARE DENOTED BY M'S IF THEY COINCIDE WITH *'S, N'S OTHERWISE
Final Report
1-1729.005
MEAN 4.667 5.667
STD.DEV. 1.914 1.124
R.E.S.D. 2.183 1.262
S. E. M. 1.105 .649
MAXIMUM 6.800 6.900
MINIMUM 3.100 4.700
SAMPLE SIZE 3 3 2.800
1.493
1.740
.862
3.900
1.100
3 5.300
2.207
2.354
1.274
7.600
3.200
3
****************************#**
ALL GROUPS COMBINED ANALYSIS OF VARIANCE TABLE ********A**********************
*
* SOURCE SUM OF SQUARES DF MEAN SQUARE F VALUE TAIL PROBABILITY
*
MEAN 4.608 * BETWEEN GROUPS 14.6158 3 4.8719 1.62 .2599
STD.DEV. 1.875 * WITHIN GROUPS 24.0533 8 3.0067
R.E.S.D. 1.607 * p > 0.05;
S. E. M. .541 * TOTAL 38.6692 11 NOT SIGNIFICANT
*******************************************************************A****/.*****#*************
MAXIMUM 7.600
MINIMUM 1.100 * LEVENE'S TEST FOR EQUAL VARIANCES 3, 8 .48 .7036
************************************R*******************************1.****k******************
SAMPLE SIZE 12
* ONE-WAY ANALYSIS OF VARIANCE
* TEST STATISTICS FOR WITHIN-GROUP
* VARIANCES NOT ASSUMED TO BE EQUAL
* WELCH 3, 4 1.86 .2774
* BROWN-FORSYTHE 3, 7 1.62 .2692
N90y4699

Final Report
I-1729.005
X. REFERENCES
Bertalanffy, F.D. Tritiated Thymidine Versus Colchicine
Technique in the Study of Cell Population Cytodynamics. Lab.
Investigation, 13:871-884, 1964.
Burke, M.D., and Mayer, R.T. Ethoxyresorufin: Direct
Fluorometric Assay of a Microsomal-O-Dealkylation Which Is
Preferentially Inducible By 3-Methylcholanthrene. Drug Metab.
Disp. 2:583, 1974.
Coles, E.H. Veterinary Clinical Pathology. Third Edition.
Philadelphia: W.B. Saunders Co., 1980.
Dixon, W.J., and Brown, M.B. BMDP-79, Biomedical Computer
Programs, P-Series. Berkeley: University of California Press,
1979.
Dungworth, D.L., Schwartz, L.W., Tyler, W.S. and Phalen, R.F.
Morphological Methods for Evaluation of Pulmonary Toxicity in
Animals. Ann. Rev. Pharmacol. Toxicol. 16:381-399, 1976.
Guerin, M.R., Stokely, J.R., Higgins, C.E., Moneyhun, J.H., and
Holmberg, R.W. Inhalation Bioassay Chemistry - Walton Horizontal
Smoking Machine for Inhalation Exposure of Rodents to Cigarette
Smoke. J. Natl. Can. Inst., 63:441-448, 1979.
Henry, C.J., Whitmire, C.E., Lopez, A., Dansie, D.R., Avery, M.
D., Caton, J.E., Stokely, J.R., Holmberg, R.W., Guerin, M.R., and
Kouri, R.E. The Dosimetry and Distribution of Whole Cigarette
Smoke Particulates in Inbred Strains of Mice: Comparison of a
Large Smoke- Exposure Machine (SEM) with a Small Capacity Smoke
Exposure Machine (Walton). In: Pulmonary Toxicology of Respirable
Particles, C.L. Sanders, F.T. Cross, G.E. Dagle, and J.A.
Mahaffey (Eds.), Technical Information Center, U.S. Department of
Energy, NTIS, pp. 177-192, 1980.
Kanagalingam, K.K., Banerjee, A., Reed, S.M., Dansie, D.R.,
Benedict, W.F., Kouri, R.E., and Henry, C.J. Cigarette Smoke
Increases DNA Replication in Lung and Sister Chromatid Exchange
(SCE) in Bone Marrow of Mice. Proc. of Am. Assoc. Can. Res.,
23:56, 1982.
23

Final Report
I-1729.005
Kouri, R.E., and Nebert, D.W. Genetic Regulation of
Susceptibility to Polycyclic Hydrocarbon-Induced Tumors in the
Mouse. In: Origins of Human Cancer, H.H. Hiatt, J.D. Watson, and
J.A. Winsten, eds., Cold Spring Harbor Press, pp. 811-835, 1977.
Kouri, R.E., Rude, T., Thomas, P.E., and Whitmire, C.E. Studies
on Pulmonary Aryl Hydrocarbon Hydroxylase Activity in Inbred
Strains of Mice. Chem. Biol. Interactions, 13:317-331, 1976.
Lamb, D. and L. Reid. Mitotic Rates, Goblet Cell Increase and
Histochemical Changes in Mucus in Mice Bronchial Epithelium
During Exposure to Sulphur Dioxide. J. Path. Bact. 96:97-111,
1968
Mitruka, B.M. and Rawnsley, H.M. Clinical Biochemical and
Hematological Reference Values in Normal Experimental Animals.
Second Edition. New York: Masson Publishing USA, Inc., 1981.
Sokal, R.R. and Rohlf, F.J. Biometry, The Principles and
Practice of Statistics in Biological Research. San Francisco:
W.H. Freeman and Co., 1969.
Young, J.T. Histopathologic Examination of the Rat Nasal Cavity,
Fund & Applied Tox., 1:309-312, 1981.
24

QUALITY ASSURANCE STATEMENT
Study Title: SIX WEEK REPEATED SMOKE INHALATION
IN MICE TO COMPARE HISTOPATHOLOGY AND
SHORT-TERM ENDPOINTS USING TEST (D6 AND Dl0)
AND REFERENCE CIGARETTES
Study Number: 11729.005
Study Director: Raymond
M. David, Ph.D.
Initiation Date: 83/03/24
Review Completed Date: 85/10/11
This study has been divided into a series of phases. Using a
random sampling approach, Quality Assurance monitors each of
these phases over a series of studies. Procedures, documenta-
tion, equipment, etc., are examined in order to assure.that the
study is performed in accordance with the Good Laboratory
Practice regulations and to assure that the study is conducted
according to the protocol.
The following are the inspection dates, phases inspected, and
report dates of QA inspections of the study.
INSPECT ON 83/03/22 - 83/03/22,TO STUDY DIR 83/03/22,TO MGMT 83/03/22
PHASES: PROTOCOL REVIEW
INSPECT ON 83/04/13 - 83/04/13,TO STUDY DIR 83/04/14,TO MGMT 83/07/01
PHASES: BLOOD COLLECTION FOR CLINICAL CHEMISTRY
NECROPSY
INSPECT ON 83/06/20 - 83/06/22,TO STUDY DIR 83/06/22,TO MGMT 83/07/01
PHASES: DRAFT REPORT
INSPECT ON 83/06/30 - 83/07/01,TO STUDY DIR 83/07/01,TO MGMT 83/07/01
PHASES: PATHOLOGY REPORT
INSPECT ON 85/10/07 - 85/10/07,TO STUDY DIR 85/10/07,TO MGMT 85/10/11
PHASES: DRAFT TO FINAL REPORT
This report describes the methods and procedures used in the
study and the reported results accurately reflect the raw data
of the study.
1\
Quality Ass rance Date
RA/QA Department
25

Final Report
1-1729.005
PATHOLOGY REPORT
SIX WEEK REPEATED SMOKE INHALATION IN MICE
TO COMPARE HISTOPATHOLOGY AND SHORT-TERM ENDPOINTS
USING TEST (D6 and D10) AND REFERENCE CIGARETTES,
STUDY NO. 1-1729.005 (CAHS No. 1263-1)
INTRODUCTION AND METHODS
Female B6C3F1/crlBL mice were divided into sham controls, a
reference cigarette group, and 2 test cigarette groups and
exposed to repeated doses of smoke by nose-only inhalation 5 days
per week for 3 or 6 weeks. Twenty-one days after initiation of
treatment, 3 mice from each group were anesthetized by metofane
and killed by exsanguination. Forty-two days after initiation, 3
mice from each group were given colchicine (1 mg/kg) and 4 hours
later were anesthetized with metofane and killed by
exsanguination. Three additional non-colchicine-treated mice
from each group were also anesthetized and killed in an identical
manner.
All mice were necropsied. Lungs were removed and weighed to
the nearest 0.1 mg. The remaining organs and tissues were
removed from the animal and fixed in 10% neutral buffered
formalin. Lungs were fixed by perfusion with formalin to
approximate the normal expanded state. The nasal passages were
flushed with formalin and immersed in the fixative.
Nasal passages were decalcified and trimmed according to the
procedures described by Young (1981). Lung lobes were sectioned
and embedded longitudinally through the stem bronchus of each
lobe (Dungworth, et al, 1976); trachea and mainstem bronchi were
removed and embedded whole longitudinally and 3 sections of the
larynx were embedded transversely. All tissues except nasal
passages were embedded in glycol methacrylate, sectioned at 2.5
um and stained with toluidine blue. The latter were embedded in
paraffin, sectioned at 6 um, and stained with hematoxylin,
phloxine, and eosin. Sections were evaluated microscopically
without knowledge of the group being evaluated.
RESULTS
GROSS NECROPSY FINDINGS
At both the 3-week interim and 6 week terminal sacrifices,
treatment related gross lesions consisted of tan or brown
discoloration of lungs of most smoke-exposed mice but not sham
controls. No difference was discerned between reference and test
cigarette groups. Other lesions were incidental (Table 1).
1

Final Report
1-1729.005
MICROSCOPIC FINDINGS
Mice treated for 3 weeks had macrophage infiltration of
pulmonary alveoli. It was most often observed in alveoli located
near small airways. All mice of groups 1 and 2 and 1 of group 3
had this response. Lesions were graded as minimal to mild. Mice
of group 4 (sham controls) were essentially free of this
response. The response was interpreted to be attributable to
smoke inhalation. A difference was not observed between
reference and test cigarettes.
All mice of both six weeks treatment groups (colchicine and
non-colchicine), had minimal or mild alveolar macrophage
infiltrates in the lung. The lesion was not observed in sham
control lungs.
Another response observed in both 3 and 6 weeks treated mice
was lymphoid infiltration of the interstitium between small
airways and vessels and infrequently, lymphoid infiltration
around blood vessels of the lung. The response was
minimal-to-mild in all instances. It was observed in 2 of the 9
smoke-exposed mice in the 3 weeks study and 17 of the 18
smoke-exposed mice in the 6 weeks studies. Similar lesions were
not observed in sham controls.
Nasal cavity, trachea and lung sections were assessed for
changes in the airway epithelium. No morphologic changes were
observed in test or control mice.
DISCUSSION AND SUMMARY
Smoke related responses were observed in the lungs of female
mice exposed to smoke 5 days each week for 3 and 6 weeks
respectively. The responses included macrophage infiltration of
alveoli and lymphoid infiltration of the interstitial tissue
between small airways and vessels and infrequently around
pulmonary vessels. Grossly, lung discoloration was observed in
most smoke-exposed mice, but not sham controls. Control mice
were essentially free of gross and microscopic responses. No
differences between reference smoke and test article smoke
exposed groups could be discerned.
2

Final Report
1-1729.005
Signature Page
&~ n/ 61301s3
Anthony son, D.V.M., Ph.D. Date
Veterinary Pathologist
Reviewed by:
William C. Hall, V.M.D., Ph.D.
Director of Veterinary Pathology
Date
3

Final Report
1-1729.005
Leyend
+ = Tissue present
NR = Organ not required
1 = Minimal
2 = Mild
3 = Moderate
4 = Severe
TS = Terminal Sacrifice
IS = Interim Sacrifice
FD = Found Dead
X = Lesion present but not graded
- = Required organ not present

Final Report
1-1729.005
TABLE 1 Gross Necropsy Findings (CAHS 1263-1)
GROUP INDIVIDUAL
ANIMAL NO.
GROSS OBSERVATIONS
INTERIM SACRIFICE - 3 WEEKS
4 1187 Lungs - Red
1 1145 Lungs - Slightly tan
1 1147
2 1157
2 1158
2 1159
3 1169
3 1170
3 1170 Thymus - Slightly enlarged
3 1173 Gums - Pale
3 1173 Tongue - Pale
4 1187 Stomach - Distended with Air
4 1187 Upper Intestines - Distended with Air
TERMINAL SACRIFICE - 6 WEEKS
1 1151 Lungs - Brown Discoloration
1 1152
1 1153
2 1163
2 1164
2 1165
3 1175
3 1176
3 1177
TERMINAL SACRIFICE - 6 WEEKS - COLCHICiNE TREATMENT
1160 Mesenteric Lymph Node - Hemorrhage
2 1161 Mesentery - Hemorrhage
2 1160 Lungs - Brown Discoloration T
2 1161 m
2 1162 t0
~
3 1171 T
3 1172 O
3 1174 ~
~:

Final Report
1-1729.005
TABLE 2 Individual Animal Microscopic Findings (CAHS 1^63-1)
(3 Weeks)
Group Number 1 1 1 2 2 2 3 3 3 4 4 4
An imal Number 1145 1146 1147 1157 1158 1159 1169 1170 1173 1181 1182 1187
Histology Number 83-1229 83-1230 83-1231 83-1232 83-1233 83-1234
83-1235 83-1236 83-1237 83-1238 83-1239 83-1240
Date of Death
Type of Death 04/13/83
IS 04/13/83 04/13/83 04/13/83 04/13/83 04/13/83 04/13/83
IS IS IS IS IS IS 04/13/83
IS 04/04/83
FD 04/13/83
IS 04/13/83
IS 04/11/83
FD
NASAL,ORAL,PHARYNGEAL SECTIONS + + + + + .1+ + + + + +
LUNG + + + + + + + + + + + +
Alveolar Macrophage 2 1 1 2 2 1 1
Accumulation
Lymphoid Infiltration 1 2
Congestion
LARYNX + - + + + + + + X
+ + - +
TRACHEA + + + + + + + + + + + +
THYMUS +
44094Egg

Final Report
1-1729.005
TABLE 2 (Cont'd) Individual Animal Microscopic Findings (CALIS 1263-1)
(6 Weeks)
Group Number 1 1 1 2 2 2 3 3 3 4 4 4
Animal Number 1151 1152 1153 1163 1164 1165 1175 1176 1177 1186 1188 1189
Ilistology
Number 83-1244 83-1245 83-1246 83-1250 83-1251 83-1252 83-1256 83-1257 83-1258 83-1262 83-1263 83-12
64
Date of
Death 05/04/83 05/04/83 05/04/83 05/04/83 05/04/83 05/04/83 05/04/83 05/04/83 05/04/83 05/04/83 05/0
4/83 05/04/83
Type of Death TS TS TS TS TS TS TS TS TS TS TS TS
NASAL,ORAL,PHARYNGEAL SECTIONS + + + + + + + + + + + +
LUNG + + + + + + + + + + + +
Alveolar Macrophage 2 2 2 2 2 2 2 2 1
Accumulation
L.ymphoid Infiltration
2
2,
1
1
1
1
2
2
LARYNX + + + + f + + + + + + +
TRACIIEA + + + + + + + + + + + +
Nf.lV J&GpR

Final Report
1-1729.005
TABLE 2(Cont'd) Individual Animal Microscopic Findings (CAHS 1263-1)
- (6 Weeks - Colchicine Treatment)
Group Number 1 1 1 2 2 2 3 3 3 4 4 4
Animal Number 1148 1149 1150 1160 1161 1162 1171 1172 1174 1183 1184 1185
Histology
Number 83-1241 83-1242 83-1243 83-1247 83-1248 83-1249 83-1253 83-1254 83-1255 83-1259 83-1260 83-12
61
Date of
Death 05/04/83 05/04/83 05/04/83 05/04/83 05/04/83 05/04/83 05/04/83 05/04/83 05/04/83 05/04/83 05/0
4/83 05/04/83
Type of Death TS TS TS TS TS TS TS TS TS TS TS TS
NASAL, ORAL, PIIARYNGEAL SECTIONS + + + + + + + + + + + +
LUNG + + + + + + + + + + + +
Alveolar Macrophage 2 2 2 2 2 2 2 1 1
Accumulation
Lymphoid Infiltration
2
2
2
2
1
1
2
1
1
LARYNX + + + + + + + + + + + +
TRACHEA + + + + + + + + + + + i
f4U9L6Bd
